CA2215912C - Pre-filled syringe drug delivery system - Google Patents
Pre-filled syringe drug delivery system Download PDFInfo
- Publication number
- CA2215912C CA2215912C CA002215912A CA2215912A CA2215912C CA 2215912 C CA2215912 C CA 2215912C CA 002215912 A CA002215912 A CA 002215912A CA 2215912 A CA2215912 A CA 2215912A CA 2215912 C CA2215912 C CA 2215912C
- Authority
- CA
- Canada
- Prior art keywords
- syringe
- barrel
- fluid
- syringe assembly
- reciprocable stopper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/284—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle comprising means for injection of two or more media, e.g. by mixing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3101—Leak prevention means for proximal end of syringes, i.e. syringe end opposite to needle mounting end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3106—Plugs for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3117—Means preventing contamination of the medicament compartment of a syringe
- A61M2005/3121—Means preventing contamination of the medicament compartment of a syringe via the proximal end of a syringe, i.e. syringe end opposite to needle cannula mounting end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3128—Incorporating one-way valves, e.g. pressure-relief or non-return valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
- A61M2005/31506—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit formed as a single piece, e.g. moulded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31501—Means for blocking or restricting the movement of the rod or piston
- A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31596—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
- A61M2005/31598—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing having multiple telescopically sliding coaxial pistons encompassing volumes for components to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/285—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
- A61M5/286—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened upon internal pressure increase, e.g. pierced or burst
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/28—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
- A61M5/285—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened
- A61M5/288—Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened by piercing without internal pressure increase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M5/31515—Connection of piston with piston rod
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
- A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/50—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
- A61M5/5013—Means for blocking the piston or the fluid passageway to prevent illegal refilling of a syringe
- A61M5/502—Means for blocking the piston or the fluid passageway to prevent illegal refilling of a syringe for blocking the piston
Abstract
A drug delivery system includes first drug (110) and second diluent (182) syringe assemblies which are respectively pre-filled with a drug concentrate and a liquid diluent. Th e diluent syringe assembly is positionable in operative association within a sterility maintenance sleeve (150) of the first syringe assembly so that the assemblies are joined in fluid communication. This fluid transfe r connection permits the diluent to be transferred from the second syringe assembly into a sterile mixing chamber defined by a reciprocable stopper (134) in the first syringe assembly. Thereafter, the second syringe assembly can be moved with respect to the barrel of the first syringe assembly so that the resulting mixture can be delivered for patient administration.
Description
PRE-FILLED SYRINGE DRUG DELIVERY SYSTEM
TECHNICAL FIELD
The present invention relates generally to medical devices for the preparation and administration of drugs and other therapeutic solutions, and more particularly to a drug delivery system which includes first and second syringe assemblies which are pre-filled with a drug and a liquid diluent, respectively. The syringe assemblies are positionable in a generally telescopic relationship with each other for mixing the drug with the diluent, and thereafter administering the resultant mixture to a patient.
BACKGROUND OF THE INVENTION
Modem healthcare facilities typically require the preparation and administration to patients of a very large number of pharmaceutical solutions such as intravenous drug solutions and other medicaments. In some instances, premixed solutions are provided to the healthcare facility, with subsequent administration to the patient in this ready to use form.
However, some drug compositions are supplied in a concentrated form, which may be either liquid or particulate in nature. Preparation of the solution for administration to the patient may require mixing, either for dilution or reconstitution, with a sterile liquid, such as sterile water or saline. Efficient storage and handling of such concentrated compositions is facilitated since the drugs are not as bulky as they would be if supplied in the diluted concentration (i.e. premixed or ready to use).
The drug delivery system of the present invention has been particularly configured to facilitate efficient and convenient preparation and administration of drug solutions and other wet or dry medicaments. Pre-filled syringe assemblies are provided which are conveniently operable to dilute a concentrated drug composition or to reconstitute a drug in dry form, and thereafter to administer the resultant solution.
DOCSMTL: 1949101\1 SUMMARY OF THE INVENTION
The syringe drug delivery system of the present invention includes first and second pre-filled syringe assemblies which are positionable in a generally telescopic relationship with each other for effecting preparation of a drug-containing solution, and subsequent administration of the same. This is achieved by providing a first syringe assembly with a selected quantity of a concentrated drug or other medicament, which may be in dry, particulate form, or in the form of a liquid concentrate. The second syringe assembly can be pre-filled, or filled just prior to use, with a liquid diluent or the like, such as a sterile saline solution. The syringe assemblies are positioned in operative association with each other so that the liquid diluent can be mixed with the drug concentrate, and the resultant mixture thereafter administered from the assembled first and second syringes. The entire system is preferably configured for single use, so that the entire arrangement can thereafter be disposed of economically.
In one embodiment of the invention, the drug delivery system includes a first syringe assembly including a first syringe barrel having an open end and an opposite, delivery end which defines a drug delivery passage. The first syringe assembly further includes a reciprocable stopper internally positioned within the first syringe barrel in slidably sealing engagement therewith. The reciprocable stopper defines an expandable, internal mixing chamber within the first syringe barrel. The mixing chamber is in fluid communication with the delivery passage.
A sterility maintenance sleeve extends from the reciprocable stopper toward the open end of the barrel of the first syringe assembly. The sterility maintenance sleeve maintains the sterility of the inside surface of the first syringe barrel while accommodating movement of the reciprocable stopper outwardly and then inwardly within the first syringe barrel.
The delivery system further includes a second syringe assembly including a second syringe barrel having a fluid discharge passage at one end thereof A movable piston llOCSM"PL:1949101\1 -2a-plunger is positionable within the second syringe barrel to define a fluid chamber therein. The fluid chamber is in fluid communication with the fluid discharge passage.
The first syringe assembly is preferably pre-filled with a drug concentrate, which is sealed within the internal mixing chamber. The second syringe assembly can be pre-filled with a liquid diluent held in the fluid chamber.
In order to mix the drug concentrate and the liquid diluent provided in the first and second syringe assemblies, the drug delivery system of the present invention includes a fluid transfer connector means or coupling means for joining the fluid chamber of the second syringe assembly in fluid communication with the internal mixing chamber of the first syringe assembly. Such fluid communication is achieved when the second syringe assembly is positioned, in a generally telescopic relationship with the first syringe assembly, so that the second syringe assembly is directly or indirectly connected with, or in engagement with, the reciprocable stopper of the first syringe assembly.
In one form of the invention, the connector arrangement includes a cannula which is mounted on the second syringe assembly and which is insertable through the reciprocable stopper of the first syringe assembly as the first and second syringe assemblies are telescopically joined. Further, the reciprocable stopper of the first syringe assembly and the syringe barrel of the second syringe assembly respectively include threaded connecting means for threadably connecting the second syringe barrel to the reciprocable stopper. As the second syringe barrel and the reciprocable stopper are threadably connected, the cannula mounted on the second syringe assembly is being inserted through the reciprocable stopper.
In another embodiment, the reciprocable stopper is elastomeric and hollow and includes a slit valve having flaps or lips normally biased closed. The reciprocable stopper has a receiving cavity for receiving the enlarged head of the sterility maintenance sleeve. The sterility maintenance sleeve is also connectable to the syringe barrel of the second syringe assembly. The sterility maintenance sleeve also has an outlet passage DOCSMTL: 1949101\1 establishing fluid communication between the diluent in the second syringe assembly barrel and the slit valve of the reciprocable stopper.
With either embodiment, once the first and second syringe assemblies are operatively connected, the liquid diluent within the fluid chamber of the second syringe assembly can be caused to flow into the internal mixing chamber of the first syringe assembly by movement of the piston plunger of the second syringe assembly within the syringe barrel of the second syringe assembly. During this action, hydraulic pressure expands the expandable internal mixing chamber of the first syringe assembly by moving the reciprocable stopper toward the open end of the first syringe barrel. The drug concentrate in the mixing chamber is thereby mixed with the diluent flowing from the second syringe assembly.
After mixing is complete, the resultant mixture is caused to flow from the mixing chamber by movement of the second syringe assembly together with the reciprocable stopper and sterility maintenance sleeve inwardly in the first syringe barrel of the first syringe assembly. The resultant mixture flows out of the first syringe assembly through the delivery passage which is in fluid communication with the internal mixing chamber.
The delivery passage can be connected to a suitable connector or tubing or the like for administration of the drug mixture to a patient.
Thus in accordance with one aspect of the invention there is provided a drug delivery system, comprising: a first pre-filled syringe assembly comprising: a first syringe barrel having an interior surface, an open end, and an opposite delivery end which defines a drug delivery passage; a reciprocable stopper slidably disposed within said first syringe barrel in sealing engagement therewith for defining an internal mixing chamber within said first syringe barrel in communication with said delivery passage; and a sterility maintenance sleeve extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance sleeve maintaining the sterility of the interior surface of said first syringe barrel; a second pre-filled syringe assembly comprising a second syringe barrel having a fluid discharge passage at one end thereof, DOCSMTL: 1949101\1 -3a-said second syringe barrel being sized to be disposed within the sterility maintenance sleeve of said first syringe assembly; a movable piston plunger positionable within said second syringe barrel to define a fluid chamber therewith in communication with said fluid discharge passage; and a liquid in the fluid chamber of said second syringe barrel;
and said system further including fluid transfer connector means for providing fluid communication from the fluid chamber of said second syringe assembly to said internal mixing chamber of said first syringe assembly when said second syringe assembly is disposed within said sterility maintenance sleeve so that the liquid within said fluid chamber can be caused to flow through said fluid transfer connector means into said internal mixing chamber of said first syringe assembly by movement of said piston plunger toward said fluid discharge passage of said second syringe assembly and thereafter caused to flow from said mixing chamber of said first syringe assembly through said drug delivery passage by movement of said second syringe assembly together with said reciprocable stopper and said sterility maintenance sleeve toward the drug delivery passage of said first syringe assembly, and said fluid transfer connector means includes means for regulating the flow of fluid through said reciprocable stopper.
In one embodiment of the invention the reciprocable stopper has an outer side facing toward said open end of said first syringe barrel and an inner side facing toward said drug delivery passage, said means for regulating the flow of fluid through said reciprocable stopper comprises said reciprocable stopper having a resilient body with a longitudinal slit through the resilient body defining two normally closed resilient lips, and the resilient body of said reciprocable stopper is substantially hollow and includes an enlarged cavity and a smaller entrance passage; and said sterility maintenance sleeve further includes: an enlarged head for being received in said enlarged cavity un said enlarged cavity of said resilient body, a smaller neck for being received in said smaller entrance passage of said resilient body, and a radially extending support flange adjacent said smaller neck for axially supporting said reciprocable stopper outer side.
DOCSMTL: 1949101\1 In another embodiment of the invention the means for regulating the flow of fluid through said reciprocable stopper comprises a normally closed, pressure actuatable valve, and said second syringe assembly and said sterility maintenance sleeve define means for engaging which comprises: a luer nozzle at said fluid discharge passage of said second syringe assembly, and a cooperating luer socket in said sterility maintenance sleeve.
In another aspect of the invention there is provided a syringe system comprising:
a first syringe assembly including: a first barrel having an interior surface, an open end, and a delivery end defining a delivery passage to accommodate the delivery of a fluid mixture from said first barrel; a reciprocable stopper slidably disposed in said first barrel and defining a mixing chamber between said delivery end of said first barrel and said reciprocable stopper; a sterility maintenance member connected to and extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance member maintaining the sterility of the interior surface of said first syringe barrel; and a first constituent in said mixing chamber; a second syringe assembly including a second barrel that is sized to be disposed in said sterility maintenance member and that has a discharge end defining a discharge passage communicating through said discharge end to accommodate the discharge of fluid from said second barrel; a moveable piston plunger slidably disposed within said second barrel and defining a second chamber between said discharge end and said piston plunger;
and a liquid second constituent in said second chamber; wherein the reciprocable stopper and sterility maintenance member are engageable to cooperatively define a coupling means accommodating the flow of said liquid second constituent from said second syringe barrel into said mixing chamber as said second syringe assembly, together with the engaged sterility maintenance sleeve and reciprocable stopper move outwardly relative to said mixing chamber, said coupling means includes means for controlling fluid flow from said second chamber into said first chamber, said fluid flow controlling means includes a one-way pressure actuatable valve biased to a normally closed position, said reciprocable stopper is made of a resilient material and has an inner side which DOCSMTL: 1949101\1 -4a-conically tapers to an apex toward said first chamber and includes a reduced thickness portion at the apex of the conical shape with at least one slit through the apex into the first chamber to define said one-way pressure actuatable valve, said at least one slit defines opposed lips in said reciprocable stopper which are caused to resiliently open into said first chamber by fluid pressure from said second chamber, said reciprocable stopper further includes an outer side facing toward said first syringe barrel open end, said reciprocable stopper having an enlarged receiving cavity and a smaller entrance passage extending from said outer side to said enlarged cavity whereby the opening of said lips establishes communication from said enlarged cavity through said reciprocable stopper into said first chamber and whereby said lips are normally biased to a closed position, said sterility maintenance member includes a generally cylindrical sleeve; and said coupling means further includes a support structure on said sterility maintenance member, said support structure including an enlarged head and an adjacent smaller neck, said enlarged head being sealingly engaged with said enlarged receiving cavity of said reciprocable stopper and said smaller neck extending through said entrance passage of said reciprocable stopper, said sterility maintenance sleeve support structure defining a central passageway through said enlarged head and smaller neck whereby said central passageway is normally occluded by said closed lips.
Other features and advantages of the present drug delivery system will become readily apparent from the following detailed description, the accompanying drawings.
DOCSMTL: 1949101\1 BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is an exploded perspective view illustrating the drug delivery system embodying the principles of a first embodiment of the present invention;
FIG. 2 is a cross-sectional view of a first syringe assembly of the first embodiment, which assembly is pre-filled with a drug concentrate designated M;
FIG. 3 is a cross-sectional view illustrating a second syringe assembly of the first embodiment, which second syringe assembly is pre-filled with a liquid diluent D;
FIG. 4 is a cross-sectional, fragmentary view of the second syringe assembly;
FIGS. 5 and 6 are cross-sectional views of the first embodiment and illustrate insertion of the second syringe assembly telescopically into the first syringe assembly;
FIG. 7 is a cross-sectional view further illustrating the first embodiment after mixture of the drug concentrate with the liquid diluent;
FIG. 8 is a further cross-sectional view illustrating the first embodiment after administration of the drug mixture;
DOCSMTL: 1949101\1 FIGURE 9 is a perspective view illustrating the first syringe assembly and the second syringe assembly of the drug delivery system embodying the principles of a presently preferred, second embodiment of the invention;
FIGURE 10 is a cross-sectional view of a first syringe assembly of the second preferred embodiment shown in FIGURE 9, and shows the first syringe assembly pre-filled with a drug concentrate designated M and sealed with a reciprocable stopper to which is mounted a sterility maintenance sleeve and a plug;
FIGURE 11 is a cross-sectional view illustrating a second syringe assembly of the preferred embodiment, which second syringe assembly is pre-filled with a liquid diluent D for use with the first syringe assembly shown in FIGURE 10;
FIGURE 12 is a cross-sectional view of the preferred embodiment of the components shown in FIGURE 9 with the plug removed and the second syringe assembly telescopically inserted into the sterility maintenance sleeve in the first syringe assembly;
FIGURE 13 is a cross-sectional view of the preferred embodiment similar to FIGURE 12 and illustrates the advancement of the movable piston plunger of the second syringe assembly to establish fluid communication between the fluid chamber of the second syringe assembly and the mixing chamber of the first syringe assembly to cause fluid transfer of the liquid diluent D from the fluid chamber to the mixing chamber;
FIGURE 14 is a cross-sectional view, similar to FIGURE 13, further illustrating the preferred embodiment after mixture of the drug concentrate with the liquid diluent;
TECHNICAL FIELD
The present invention relates generally to medical devices for the preparation and administration of drugs and other therapeutic solutions, and more particularly to a drug delivery system which includes first and second syringe assemblies which are pre-filled with a drug and a liquid diluent, respectively. The syringe assemblies are positionable in a generally telescopic relationship with each other for mixing the drug with the diluent, and thereafter administering the resultant mixture to a patient.
BACKGROUND OF THE INVENTION
Modem healthcare facilities typically require the preparation and administration to patients of a very large number of pharmaceutical solutions such as intravenous drug solutions and other medicaments. In some instances, premixed solutions are provided to the healthcare facility, with subsequent administration to the patient in this ready to use form.
However, some drug compositions are supplied in a concentrated form, which may be either liquid or particulate in nature. Preparation of the solution for administration to the patient may require mixing, either for dilution or reconstitution, with a sterile liquid, such as sterile water or saline. Efficient storage and handling of such concentrated compositions is facilitated since the drugs are not as bulky as they would be if supplied in the diluted concentration (i.e. premixed or ready to use).
The drug delivery system of the present invention has been particularly configured to facilitate efficient and convenient preparation and administration of drug solutions and other wet or dry medicaments. Pre-filled syringe assemblies are provided which are conveniently operable to dilute a concentrated drug composition or to reconstitute a drug in dry form, and thereafter to administer the resultant solution.
DOCSMTL: 1949101\1 SUMMARY OF THE INVENTION
The syringe drug delivery system of the present invention includes first and second pre-filled syringe assemblies which are positionable in a generally telescopic relationship with each other for effecting preparation of a drug-containing solution, and subsequent administration of the same. This is achieved by providing a first syringe assembly with a selected quantity of a concentrated drug or other medicament, which may be in dry, particulate form, or in the form of a liquid concentrate. The second syringe assembly can be pre-filled, or filled just prior to use, with a liquid diluent or the like, such as a sterile saline solution. The syringe assemblies are positioned in operative association with each other so that the liquid diluent can be mixed with the drug concentrate, and the resultant mixture thereafter administered from the assembled first and second syringes. The entire system is preferably configured for single use, so that the entire arrangement can thereafter be disposed of economically.
In one embodiment of the invention, the drug delivery system includes a first syringe assembly including a first syringe barrel having an open end and an opposite, delivery end which defines a drug delivery passage. The first syringe assembly further includes a reciprocable stopper internally positioned within the first syringe barrel in slidably sealing engagement therewith. The reciprocable stopper defines an expandable, internal mixing chamber within the first syringe barrel. The mixing chamber is in fluid communication with the delivery passage.
A sterility maintenance sleeve extends from the reciprocable stopper toward the open end of the barrel of the first syringe assembly. The sterility maintenance sleeve maintains the sterility of the inside surface of the first syringe barrel while accommodating movement of the reciprocable stopper outwardly and then inwardly within the first syringe barrel.
The delivery system further includes a second syringe assembly including a second syringe barrel having a fluid discharge passage at one end thereof A movable piston llOCSM"PL:1949101\1 -2a-plunger is positionable within the second syringe barrel to define a fluid chamber therein. The fluid chamber is in fluid communication with the fluid discharge passage.
The first syringe assembly is preferably pre-filled with a drug concentrate, which is sealed within the internal mixing chamber. The second syringe assembly can be pre-filled with a liquid diluent held in the fluid chamber.
In order to mix the drug concentrate and the liquid diluent provided in the first and second syringe assemblies, the drug delivery system of the present invention includes a fluid transfer connector means or coupling means for joining the fluid chamber of the second syringe assembly in fluid communication with the internal mixing chamber of the first syringe assembly. Such fluid communication is achieved when the second syringe assembly is positioned, in a generally telescopic relationship with the first syringe assembly, so that the second syringe assembly is directly or indirectly connected with, or in engagement with, the reciprocable stopper of the first syringe assembly.
In one form of the invention, the connector arrangement includes a cannula which is mounted on the second syringe assembly and which is insertable through the reciprocable stopper of the first syringe assembly as the first and second syringe assemblies are telescopically joined. Further, the reciprocable stopper of the first syringe assembly and the syringe barrel of the second syringe assembly respectively include threaded connecting means for threadably connecting the second syringe barrel to the reciprocable stopper. As the second syringe barrel and the reciprocable stopper are threadably connected, the cannula mounted on the second syringe assembly is being inserted through the reciprocable stopper.
In another embodiment, the reciprocable stopper is elastomeric and hollow and includes a slit valve having flaps or lips normally biased closed. The reciprocable stopper has a receiving cavity for receiving the enlarged head of the sterility maintenance sleeve. The sterility maintenance sleeve is also connectable to the syringe barrel of the second syringe assembly. The sterility maintenance sleeve also has an outlet passage DOCSMTL: 1949101\1 establishing fluid communication between the diluent in the second syringe assembly barrel and the slit valve of the reciprocable stopper.
With either embodiment, once the first and second syringe assemblies are operatively connected, the liquid diluent within the fluid chamber of the second syringe assembly can be caused to flow into the internal mixing chamber of the first syringe assembly by movement of the piston plunger of the second syringe assembly within the syringe barrel of the second syringe assembly. During this action, hydraulic pressure expands the expandable internal mixing chamber of the first syringe assembly by moving the reciprocable stopper toward the open end of the first syringe barrel. The drug concentrate in the mixing chamber is thereby mixed with the diluent flowing from the second syringe assembly.
After mixing is complete, the resultant mixture is caused to flow from the mixing chamber by movement of the second syringe assembly together with the reciprocable stopper and sterility maintenance sleeve inwardly in the first syringe barrel of the first syringe assembly. The resultant mixture flows out of the first syringe assembly through the delivery passage which is in fluid communication with the internal mixing chamber.
The delivery passage can be connected to a suitable connector or tubing or the like for administration of the drug mixture to a patient.
Thus in accordance with one aspect of the invention there is provided a drug delivery system, comprising: a first pre-filled syringe assembly comprising: a first syringe barrel having an interior surface, an open end, and an opposite delivery end which defines a drug delivery passage; a reciprocable stopper slidably disposed within said first syringe barrel in sealing engagement therewith for defining an internal mixing chamber within said first syringe barrel in communication with said delivery passage; and a sterility maintenance sleeve extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance sleeve maintaining the sterility of the interior surface of said first syringe barrel; a second pre-filled syringe assembly comprising a second syringe barrel having a fluid discharge passage at one end thereof, DOCSMTL: 1949101\1 -3a-said second syringe barrel being sized to be disposed within the sterility maintenance sleeve of said first syringe assembly; a movable piston plunger positionable within said second syringe barrel to define a fluid chamber therewith in communication with said fluid discharge passage; and a liquid in the fluid chamber of said second syringe barrel;
and said system further including fluid transfer connector means for providing fluid communication from the fluid chamber of said second syringe assembly to said internal mixing chamber of said first syringe assembly when said second syringe assembly is disposed within said sterility maintenance sleeve so that the liquid within said fluid chamber can be caused to flow through said fluid transfer connector means into said internal mixing chamber of said first syringe assembly by movement of said piston plunger toward said fluid discharge passage of said second syringe assembly and thereafter caused to flow from said mixing chamber of said first syringe assembly through said drug delivery passage by movement of said second syringe assembly together with said reciprocable stopper and said sterility maintenance sleeve toward the drug delivery passage of said first syringe assembly, and said fluid transfer connector means includes means for regulating the flow of fluid through said reciprocable stopper.
In one embodiment of the invention the reciprocable stopper has an outer side facing toward said open end of said first syringe barrel and an inner side facing toward said drug delivery passage, said means for regulating the flow of fluid through said reciprocable stopper comprises said reciprocable stopper having a resilient body with a longitudinal slit through the resilient body defining two normally closed resilient lips, and the resilient body of said reciprocable stopper is substantially hollow and includes an enlarged cavity and a smaller entrance passage; and said sterility maintenance sleeve further includes: an enlarged head for being received in said enlarged cavity un said enlarged cavity of said resilient body, a smaller neck for being received in said smaller entrance passage of said resilient body, and a radially extending support flange adjacent said smaller neck for axially supporting said reciprocable stopper outer side.
DOCSMTL: 1949101\1 In another embodiment of the invention the means for regulating the flow of fluid through said reciprocable stopper comprises a normally closed, pressure actuatable valve, and said second syringe assembly and said sterility maintenance sleeve define means for engaging which comprises: a luer nozzle at said fluid discharge passage of said second syringe assembly, and a cooperating luer socket in said sterility maintenance sleeve.
In another aspect of the invention there is provided a syringe system comprising:
a first syringe assembly including: a first barrel having an interior surface, an open end, and a delivery end defining a delivery passage to accommodate the delivery of a fluid mixture from said first barrel; a reciprocable stopper slidably disposed in said first barrel and defining a mixing chamber between said delivery end of said first barrel and said reciprocable stopper; a sterility maintenance member connected to and extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance member maintaining the sterility of the interior surface of said first syringe barrel; and a first constituent in said mixing chamber; a second syringe assembly including a second barrel that is sized to be disposed in said sterility maintenance member and that has a discharge end defining a discharge passage communicating through said discharge end to accommodate the discharge of fluid from said second barrel; a moveable piston plunger slidably disposed within said second barrel and defining a second chamber between said discharge end and said piston plunger;
and a liquid second constituent in said second chamber; wherein the reciprocable stopper and sterility maintenance member are engageable to cooperatively define a coupling means accommodating the flow of said liquid second constituent from said second syringe barrel into said mixing chamber as said second syringe assembly, together with the engaged sterility maintenance sleeve and reciprocable stopper move outwardly relative to said mixing chamber, said coupling means includes means for controlling fluid flow from said second chamber into said first chamber, said fluid flow controlling means includes a one-way pressure actuatable valve biased to a normally closed position, said reciprocable stopper is made of a resilient material and has an inner side which DOCSMTL: 1949101\1 -4a-conically tapers to an apex toward said first chamber and includes a reduced thickness portion at the apex of the conical shape with at least one slit through the apex into the first chamber to define said one-way pressure actuatable valve, said at least one slit defines opposed lips in said reciprocable stopper which are caused to resiliently open into said first chamber by fluid pressure from said second chamber, said reciprocable stopper further includes an outer side facing toward said first syringe barrel open end, said reciprocable stopper having an enlarged receiving cavity and a smaller entrance passage extending from said outer side to said enlarged cavity whereby the opening of said lips establishes communication from said enlarged cavity through said reciprocable stopper into said first chamber and whereby said lips are normally biased to a closed position, said sterility maintenance member includes a generally cylindrical sleeve; and said coupling means further includes a support structure on said sterility maintenance member, said support structure including an enlarged head and an adjacent smaller neck, said enlarged head being sealingly engaged with said enlarged receiving cavity of said reciprocable stopper and said smaller neck extending through said entrance passage of said reciprocable stopper, said sterility maintenance sleeve support structure defining a central passageway through said enlarged head and smaller neck whereby said central passageway is normally occluded by said closed lips.
Other features and advantages of the present drug delivery system will become readily apparent from the following detailed description, the accompanying drawings.
DOCSMTL: 1949101\1 BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is an exploded perspective view illustrating the drug delivery system embodying the principles of a first embodiment of the present invention;
FIG. 2 is a cross-sectional view of a first syringe assembly of the first embodiment, which assembly is pre-filled with a drug concentrate designated M;
FIG. 3 is a cross-sectional view illustrating a second syringe assembly of the first embodiment, which second syringe assembly is pre-filled with a liquid diluent D;
FIG. 4 is a cross-sectional, fragmentary view of the second syringe assembly;
FIGS. 5 and 6 are cross-sectional views of the first embodiment and illustrate insertion of the second syringe assembly telescopically into the first syringe assembly;
FIG. 7 is a cross-sectional view further illustrating the first embodiment after mixture of the drug concentrate with the liquid diluent;
FIG. 8 is a further cross-sectional view illustrating the first embodiment after administration of the drug mixture;
DOCSMTL: 1949101\1 FIGURE 9 is a perspective view illustrating the first syringe assembly and the second syringe assembly of the drug delivery system embodying the principles of a presently preferred, second embodiment of the invention;
FIGURE 10 is a cross-sectional view of a first syringe assembly of the second preferred embodiment shown in FIGURE 9, and shows the first syringe assembly pre-filled with a drug concentrate designated M and sealed with a reciprocable stopper to which is mounted a sterility maintenance sleeve and a plug;
FIGURE 11 is a cross-sectional view illustrating a second syringe assembly of the preferred embodiment, which second syringe assembly is pre-filled with a liquid diluent D for use with the first syringe assembly shown in FIGURE 10;
FIGURE 12 is a cross-sectional view of the preferred embodiment of the components shown in FIGURE 9 with the plug removed and the second syringe assembly telescopically inserted into the sterility maintenance sleeve in the first syringe assembly;
FIGURE 13 is a cross-sectional view of the preferred embodiment similar to FIGURE 12 and illustrates the advancement of the movable piston plunger of the second syringe assembly to establish fluid communication between the fluid chamber of the second syringe assembly and the mixing chamber of the first syringe assembly to cause fluid transfer of the liquid diluent D from the fluid chamber to the mixing chamber;
FIGURE 14 is a cross-sectional view, similar to FIGURE 13, further illustrating the preferred embodiment after mixture of the drug concentrate with the liquid diluent;
FIGURE 15 is a further cross-sectional view illustrating use of the preferred embodiment of the drug delivery system shown in FIGURE 14 for delivery and administration of the drug mixture; and FIGURE 16 is an enlarged, fragmentary, cross-sectional view ilDustrating structural details of the reciprocable stopper and the supporting structure of the sterility maintenance sleeve.
12!ETAILED DESCRIPTION
While the present invention is susceptible of embodiment in various forms, there are shown in the drawings and there will hereinafter be described only some embodiments, with the understanding that the present disclosure is to be considered as an exemplification of the irivention, and is not intended to limit the invention to the specific embodiments illustrated.
With reference first to FIGURES 1 - 3, therein is illustrated a first embodiment of a drug delivery system 10 embodying the principles of the present invention. As will be further described, the present system includes a first syringe assembly, generally designated 12, which is pre-filled with a first constituent, such as a drug concentrate or other medicament, illustrated in particulate form and generally designated M
(see FIGURE 2). The present system further includes a second syringe assembly, generally designated 14, which is positionable generally telescopically within the first syringe assembly 12 for effecting mixture of a second constituent, such as a liquid diluent D (FIGURE 3) provided in the second syringe assembly 14 with the medicament M in the first syringe assembly.
With particular reference to FIGURE 2, the first syringe assembly 12 includes a generally cylindrical first syringe barrel 16 having a cylindrical interior surface 17 and a transverse flange portion 18 at a generally open end of the barrel. The barrel 16 has a generally closed end at which a drug delivery passage 20 is defined. A removable cap or closure 22 is preferably provided to close and seal the drug delivery passage 20 prior to use of the present system.
The first syringe assembly 12 further includes an internally reciprocable stopper 26, preferably elastomeric and slidably and sealingly positioned within the interior surface of the first syringe barrel 16. The reciprocable stopper 26 defines, with the interior surface of the first syringe barrel 16, an internal mixing chamber 24 within which a drug or other medicament M is provided in either dry or liquid concentrate form.
The reciprocable stopper 26 may be alternatively described as a grommet, slidable seal, or slidable piston, and these terms may be used interchangeably.
In the first embodiment illustrated in FIGURES 1-8, the reciprocable stopper 26 is provided with a thread form or threaded sleeve portion 28 which facilitates connection of the reciprocable stopper 26 with the associated second syringe assembly 14, as will be further described. The reciprocable stopper 26 is movable or reciprocable within the first syringe barrel 16 so that the internal mixing chamber 24 can expand to accommodate mixing of the liquid diluent D from the second syringe assembly with the medicament M in the first syringe assembly. A
movable sleeve is therefore provided for maintaining the sterility of the interior surface 17 of the first syringe barrel 16. The sterility maintenance sleeve 30 is preferably connected to the reciprocable stopper 26, with the sterility maintenance sleeve 30 extending from the reciprocable stopper 26 generally toward the open end of the barrel 16. The sterility maintenance sleeve 30 further desirably acts to support and position the reciprocable stopper 26 within the barrel 16. A removable cap 32 is provided to close and seal the interior of the sterility maintenance sleeve WO 96/29106 PCT/US96l03913 30, the threaded sleeve portion 28, and the exposed portion of reciprocable stopper 26 prior to use.
The second syringe assembly 14 includes a second syringe barrel 36 having an outside diameter that is less than the inside diameter of the sterility maintenance sleeve 30 of the first syringe assembly 12 so that the entire second syringe assembly 14 can be inserted in telescopic fashion into the sterility maintenance sleeve 30 of the first syringe assembly 12. As best illustrated in FIGURE 3, the second syringe assembly 14 is of a generally conventional configuration, including a barrel 36 and a rnovable piston plunger or plunger assembly 38 having a plunger stem 39 and an elastomeric piston portion 40. The piston portion 40 is slidably positionable and sealingly engages the interior surface of the second syringe barrel 36. The plunger stem 39 of the piston plunger 38 extends generally from an open end of the second syringe barrel 36. The opposite end of the second syringe barrel 36 is generally closed to define a fluid discharge passage 42. The second syringe barrel 36 and the piston portion 40 of the movable piston plunger 38 together define an internal fluid chamber in the second syringe assembly 14. The fluid chamber is in fluid communication with the fluid passage 42.
As noted, use of the present system includes mixing of a liquid diluent D from the internal fluid chamber of the second syringe assembly 14 with the drug concentrate M held in the internal mixing chamber 24 of the first syringe assembly 12. Accordingly, the chambers of the respective syringe assemblies must be joined in fluid communication, and to this end, the second syringe assembly 14 includes a cannula assembly 44 which is preferably mounted on the second syringe assembly 14 (see FIGURE 4). The cannula assembly 44 includes a cannula 46 which is mounted on the substantially closed end of second syringe barrel 36 by a cannula mounting element 48 so that the cannula 46 is joined in fluid communication with discharge passage 42. A removable cover 51 can cover the cannula.
In a preferred embodiment (with reference to FIGURES 5 - 7), a collapsible sheath 50 is provided for enclosing the cannula 46 prior to use of the present system. As will be further described , the collapsible sheath 50 includes a penetrable end wall portion, which is penetrated by the cannula 46 during use. Sheath 50 also includes a collapsible side wall portion depending from the end wall, which side wall portion collapses as the second syringe assembly 14 is operatively connected with the first syringe assembly 12, and the cannula 46 penetrates the end wall of the sheath 50. The end wall portion may also be partially or completely pre-slit to facilitate penetration by a modified cannula 46A, which can be provided as a blunt (i.e., non-sharpened) cannula.
The reciprocable stopper 26 of the first syringe assembly 12 and the syringe barrel 36 of the second syringe assembly 14 are respectively provided with a threaded connector arrangement so that these components can be threadably connected attendant to disposition of the second syringe assembly 14 within the first syringe assembly 12.
As noted, threaded sleeve portion 28 preferably extends from the reciprocable stopper 26. A threaded collar portion 52, having a thread form or threads configured for mating engagement with the threads of the threaded sleeve portion 28, is provided, either integrally or as an attached piece, on the outer end of the second syringe barrel 36 of the second syringe assembly 14.
While the second syringe assembly 14 is, in many respects, generally conventional in configuration, the second syringe assembly 14 is preferably provided with an arrangement for locking the movable piston plunger 38 generally at its innermost disposition with respect to the second syringe barrel 36. In the illustrated embodiment, this locking arrangement comprises a locking recess 54 positioned generally at the open end of the second syringe barrel 36. The locking recess 54 is configured (such as with a snap-fit receiving groove) to receive and retain a cooperating locking flange 56 provided on the plunger stem 39 of the movable piston plunger 38. As will be further described, the provision of the locking recess 54 and locking flange 56 permits the forward movement of the movable piston plunger 38 in the second syringe barrel 36, and thereafter facilitates movement of the second syringe barrel 36 and piston plunger 38 (while locked or snapped together) in unison relative to the first syringe barrel 16 of first syringe assembly 12.
With particular reference now to FIGURES 5 and 6, use of the present system will now be described. Prior to telescopic disposition of second syringe assembly 14 generally within first syringe assembly 12, the second syringe assembly is pre-filled with liquid diluent D. The end cap 32 of the first syringe assembly 12 is then removed. Thereafter, the second syringe assembly 14 is inserted into the first syringe assembly 12, and rotated so that the threaded collar portion 52 is threadably connected to threaded sleeve portion 28. As the collar portion 52 of the second syringe barrel 36 is thus threadably joined to the threaded sleeve portion 28 of reciprocable stopper 26, collapsible sheath 50 surrounding cannula 46 is collapsed by engagement with reciprocable stopper 26. The cannula 46 thus penetrates the end wall of the collapsible sheath 50, and thereafter pierces the reciprocable stopper 26. During assembly of the first and second syringes, the reciprocable stopper 26 remains generally fixed with respect to the first syringe barrel 16, while the elastomeric piston portion 40 of the second syringe assembly remains generally fixed with respect to second syringe barrel 36.
As the threaded collar portion 52 is rotated and threadably engaged with the threaded sleeve portion 28, the cannula 46 penetrates reciprocable stopper 26. As the cannula 46 is inserted through the reciprocable stopper 26, the internal mixing chamber 24 of the first syringe assembly 12 is joined in fluid communication with the internal fluid chamber of the second syringe assembly 14. The assembled configuration of the components of the drug delivery system is illustrated in FIGURE 6.
The system is now ready for mixing of liquid diluent D with drug concentrate M by movement of the movable piston plunger 38 inwardly in the second syringe barrel 36.
By comparison of FIGURES 6 and 7, the relative repositioning of the various components of the drug delivery system will be observed.
As movable piston plunger 38 is moved into the second syringe barrel 36, the liquid diluent D flows through the fluid discharge passage 42, through the cannula 46, and into the expandable mixing chamber 24 defined by the reciprocable stopper 26 and the first syringe barrel 16 of the first syringe assembly 12. As the diluent D and drug concentrate M are mixed, the resultant solution, designated as mixture MX in FIGURE 7, is formed in the mixing chamber 24. As will be observed, flow of liquid from the second syringe assembly 14 into the mixing chamber 24 of the first syringe assembly 12 acts to move the reciprocable stopper 26, the sterility maintenance sleeve 30, and the second, syringe assembly 14 outwardly (i.e. rearward or away from the drug delivery passage 20) in the first syringe barrel 16. The second syringe barrel 36 of the second syringe assembly 14 remains attached to, or fixed with respect to, the reciprocable stopper 26, as does the cannula 46 mounted on the second syringe assembly 14.
After the piston plunger 38 has been fully inserted into the second syringe barrel 36 of the second syringe assembly 14, the cooperating locking recess 54 and locking flange 56 move into locking engagement, thereby fixing the movable piston plunger 38 against further movement relative to the second syringe barrel 36. The drug delivery system appears as illustrated in FIGURE 7, and is now ready for administration of the mixture MX which has been formed.
Use of the present system for solution administration is generally illustrated in FIGURE B. After removal of cap 22, the drug delivery passage 20 of the first syringe barrel 16 of the first syringe assembly 12 is connected in fluid communication with a suitable connector or tubing T or other suitable administration means. The second syringe assembly 14 is then pushed or urged inwardly in the first syringe barrel 16 of the first syringe assembly 12. By this action, the second syringe assembly 14, the reciprocable stopper 26, and the sterility maintenance sleeve 30 move in unison inwardly ( i.e. forward or toward the drug delivery passage 20 ) in the first syringe barrel 16, thereby causing the mixture MX to flow through the delivery passage 20. Administration of the mixture is thus complete, and the components of the system are ready for disposal.
Another embodiment of the invention, in a presently preferred form, is illustrated in FIGURES 9-16. Like the above-described first embodiment, the preferred second embodiment is a syringe system for accommodating a concentrated liquid or dry drug, by storing the concentrated drug and a liquid diluent separately, combining the concentrated drug and diluent to reconstitute the drug in solution form, and administering the mixed solution.
The system as seen in FIGURES 9 and 10 includes a first syringe assembly having a first syringe barrel 110. The first syringe barrel 110 includes a substantially closed end 112 which defines a delivery passage 114. The delivery passage preferably includes a male luer connection nozzle 102 surrounded by an annular collar 104 having an interior, female thread 106.
12!ETAILED DESCRIPTION
While the present invention is susceptible of embodiment in various forms, there are shown in the drawings and there will hereinafter be described only some embodiments, with the understanding that the present disclosure is to be considered as an exemplification of the irivention, and is not intended to limit the invention to the specific embodiments illustrated.
With reference first to FIGURES 1 - 3, therein is illustrated a first embodiment of a drug delivery system 10 embodying the principles of the present invention. As will be further described, the present system includes a first syringe assembly, generally designated 12, which is pre-filled with a first constituent, such as a drug concentrate or other medicament, illustrated in particulate form and generally designated M
(see FIGURE 2). The present system further includes a second syringe assembly, generally designated 14, which is positionable generally telescopically within the first syringe assembly 12 for effecting mixture of a second constituent, such as a liquid diluent D (FIGURE 3) provided in the second syringe assembly 14 with the medicament M in the first syringe assembly.
With particular reference to FIGURE 2, the first syringe assembly 12 includes a generally cylindrical first syringe barrel 16 having a cylindrical interior surface 17 and a transverse flange portion 18 at a generally open end of the barrel. The barrel 16 has a generally closed end at which a drug delivery passage 20 is defined. A removable cap or closure 22 is preferably provided to close and seal the drug delivery passage 20 prior to use of the present system.
The first syringe assembly 12 further includes an internally reciprocable stopper 26, preferably elastomeric and slidably and sealingly positioned within the interior surface of the first syringe barrel 16. The reciprocable stopper 26 defines, with the interior surface of the first syringe barrel 16, an internal mixing chamber 24 within which a drug or other medicament M is provided in either dry or liquid concentrate form.
The reciprocable stopper 26 may be alternatively described as a grommet, slidable seal, or slidable piston, and these terms may be used interchangeably.
In the first embodiment illustrated in FIGURES 1-8, the reciprocable stopper 26 is provided with a thread form or threaded sleeve portion 28 which facilitates connection of the reciprocable stopper 26 with the associated second syringe assembly 14, as will be further described. The reciprocable stopper 26 is movable or reciprocable within the first syringe barrel 16 so that the internal mixing chamber 24 can expand to accommodate mixing of the liquid diluent D from the second syringe assembly with the medicament M in the first syringe assembly. A
movable sleeve is therefore provided for maintaining the sterility of the interior surface 17 of the first syringe barrel 16. The sterility maintenance sleeve 30 is preferably connected to the reciprocable stopper 26, with the sterility maintenance sleeve 30 extending from the reciprocable stopper 26 generally toward the open end of the barrel 16. The sterility maintenance sleeve 30 further desirably acts to support and position the reciprocable stopper 26 within the barrel 16. A removable cap 32 is provided to close and seal the interior of the sterility maintenance sleeve WO 96/29106 PCT/US96l03913 30, the threaded sleeve portion 28, and the exposed portion of reciprocable stopper 26 prior to use.
The second syringe assembly 14 includes a second syringe barrel 36 having an outside diameter that is less than the inside diameter of the sterility maintenance sleeve 30 of the first syringe assembly 12 so that the entire second syringe assembly 14 can be inserted in telescopic fashion into the sterility maintenance sleeve 30 of the first syringe assembly 12. As best illustrated in FIGURE 3, the second syringe assembly 14 is of a generally conventional configuration, including a barrel 36 and a rnovable piston plunger or plunger assembly 38 having a plunger stem 39 and an elastomeric piston portion 40. The piston portion 40 is slidably positionable and sealingly engages the interior surface of the second syringe barrel 36. The plunger stem 39 of the piston plunger 38 extends generally from an open end of the second syringe barrel 36. The opposite end of the second syringe barrel 36 is generally closed to define a fluid discharge passage 42. The second syringe barrel 36 and the piston portion 40 of the movable piston plunger 38 together define an internal fluid chamber in the second syringe assembly 14. The fluid chamber is in fluid communication with the fluid passage 42.
As noted, use of the present system includes mixing of a liquid diluent D from the internal fluid chamber of the second syringe assembly 14 with the drug concentrate M held in the internal mixing chamber 24 of the first syringe assembly 12. Accordingly, the chambers of the respective syringe assemblies must be joined in fluid communication, and to this end, the second syringe assembly 14 includes a cannula assembly 44 which is preferably mounted on the second syringe assembly 14 (see FIGURE 4). The cannula assembly 44 includes a cannula 46 which is mounted on the substantially closed end of second syringe barrel 36 by a cannula mounting element 48 so that the cannula 46 is joined in fluid communication with discharge passage 42. A removable cover 51 can cover the cannula.
In a preferred embodiment (with reference to FIGURES 5 - 7), a collapsible sheath 50 is provided for enclosing the cannula 46 prior to use of the present system. As will be further described , the collapsible sheath 50 includes a penetrable end wall portion, which is penetrated by the cannula 46 during use. Sheath 50 also includes a collapsible side wall portion depending from the end wall, which side wall portion collapses as the second syringe assembly 14 is operatively connected with the first syringe assembly 12, and the cannula 46 penetrates the end wall of the sheath 50. The end wall portion may also be partially or completely pre-slit to facilitate penetration by a modified cannula 46A, which can be provided as a blunt (i.e., non-sharpened) cannula.
The reciprocable stopper 26 of the first syringe assembly 12 and the syringe barrel 36 of the second syringe assembly 14 are respectively provided with a threaded connector arrangement so that these components can be threadably connected attendant to disposition of the second syringe assembly 14 within the first syringe assembly 12.
As noted, threaded sleeve portion 28 preferably extends from the reciprocable stopper 26. A threaded collar portion 52, having a thread form or threads configured for mating engagement with the threads of the threaded sleeve portion 28, is provided, either integrally or as an attached piece, on the outer end of the second syringe barrel 36 of the second syringe assembly 14.
While the second syringe assembly 14 is, in many respects, generally conventional in configuration, the second syringe assembly 14 is preferably provided with an arrangement for locking the movable piston plunger 38 generally at its innermost disposition with respect to the second syringe barrel 36. In the illustrated embodiment, this locking arrangement comprises a locking recess 54 positioned generally at the open end of the second syringe barrel 36. The locking recess 54 is configured (such as with a snap-fit receiving groove) to receive and retain a cooperating locking flange 56 provided on the plunger stem 39 of the movable piston plunger 38. As will be further described, the provision of the locking recess 54 and locking flange 56 permits the forward movement of the movable piston plunger 38 in the second syringe barrel 36, and thereafter facilitates movement of the second syringe barrel 36 and piston plunger 38 (while locked or snapped together) in unison relative to the first syringe barrel 16 of first syringe assembly 12.
With particular reference now to FIGURES 5 and 6, use of the present system will now be described. Prior to telescopic disposition of second syringe assembly 14 generally within first syringe assembly 12, the second syringe assembly is pre-filled with liquid diluent D. The end cap 32 of the first syringe assembly 12 is then removed. Thereafter, the second syringe assembly 14 is inserted into the first syringe assembly 12, and rotated so that the threaded collar portion 52 is threadably connected to threaded sleeve portion 28. As the collar portion 52 of the second syringe barrel 36 is thus threadably joined to the threaded sleeve portion 28 of reciprocable stopper 26, collapsible sheath 50 surrounding cannula 46 is collapsed by engagement with reciprocable stopper 26. The cannula 46 thus penetrates the end wall of the collapsible sheath 50, and thereafter pierces the reciprocable stopper 26. During assembly of the first and second syringes, the reciprocable stopper 26 remains generally fixed with respect to the first syringe barrel 16, while the elastomeric piston portion 40 of the second syringe assembly remains generally fixed with respect to second syringe barrel 36.
As the threaded collar portion 52 is rotated and threadably engaged with the threaded sleeve portion 28, the cannula 46 penetrates reciprocable stopper 26. As the cannula 46 is inserted through the reciprocable stopper 26, the internal mixing chamber 24 of the first syringe assembly 12 is joined in fluid communication with the internal fluid chamber of the second syringe assembly 14. The assembled configuration of the components of the drug delivery system is illustrated in FIGURE 6.
The system is now ready for mixing of liquid diluent D with drug concentrate M by movement of the movable piston plunger 38 inwardly in the second syringe barrel 36.
By comparison of FIGURES 6 and 7, the relative repositioning of the various components of the drug delivery system will be observed.
As movable piston plunger 38 is moved into the second syringe barrel 36, the liquid diluent D flows through the fluid discharge passage 42, through the cannula 46, and into the expandable mixing chamber 24 defined by the reciprocable stopper 26 and the first syringe barrel 16 of the first syringe assembly 12. As the diluent D and drug concentrate M are mixed, the resultant solution, designated as mixture MX in FIGURE 7, is formed in the mixing chamber 24. As will be observed, flow of liquid from the second syringe assembly 14 into the mixing chamber 24 of the first syringe assembly 12 acts to move the reciprocable stopper 26, the sterility maintenance sleeve 30, and the second, syringe assembly 14 outwardly (i.e. rearward or away from the drug delivery passage 20) in the first syringe barrel 16. The second syringe barrel 36 of the second syringe assembly 14 remains attached to, or fixed with respect to, the reciprocable stopper 26, as does the cannula 46 mounted on the second syringe assembly 14.
After the piston plunger 38 has been fully inserted into the second syringe barrel 36 of the second syringe assembly 14, the cooperating locking recess 54 and locking flange 56 move into locking engagement, thereby fixing the movable piston plunger 38 against further movement relative to the second syringe barrel 36. The drug delivery system appears as illustrated in FIGURE 7, and is now ready for administration of the mixture MX which has been formed.
Use of the present system for solution administration is generally illustrated in FIGURE B. After removal of cap 22, the drug delivery passage 20 of the first syringe barrel 16 of the first syringe assembly 12 is connected in fluid communication with a suitable connector or tubing T or other suitable administration means. The second syringe assembly 14 is then pushed or urged inwardly in the first syringe barrel 16 of the first syringe assembly 12. By this action, the second syringe assembly 14, the reciprocable stopper 26, and the sterility maintenance sleeve 30 move in unison inwardly ( i.e. forward or toward the drug delivery passage 20 ) in the first syringe barrel 16, thereby causing the mixture MX to flow through the delivery passage 20. Administration of the mixture is thus complete, and the components of the system are ready for disposal.
Another embodiment of the invention, in a presently preferred form, is illustrated in FIGURES 9-16. Like the above-described first embodiment, the preferred second embodiment is a syringe system for accommodating a concentrated liquid or dry drug, by storing the concentrated drug and a liquid diluent separately, combining the concentrated drug and diluent to reconstitute the drug in solution form, and administering the mixed solution.
The system as seen in FIGURES 9 and 10 includes a first syringe assembly having a first syringe barrel 110. The first syringe barrel 110 includes a substantially closed end 112 which defines a delivery passage 114. The delivery passage preferably includes a male luer connection nozzle 102 surrounded by an annular collar 104 having an interior, female thread 106.
The delivery passage 114 is preferably closed with a removable closure 128 which has an internal stem 129 for occluding the delivery passage 114. The removable closure 128 also preferably includes an exterior lug or flange 108 for threadingly engaging the female thread 106 on the annular collar 104 at the delivery end of the first syringe barrel 110.
The first syringe barrel 110 has an open end 116 with a transverse flange 117. The first syringe barrel 110 is preferably cylindrical and preferably has a cylindrical interior surface 118.
When the removable closure 128 is properly secured to the first syringe barrel 110, the first syringe barrel 110 functions as a container defining an expandable mixing chamber 130 which can be filled with a predetermined quantity of a drug concentrate M which may be in a liquid or powder form. The concentrated drug M could be a lyophilized drug, for example.
A reciprocable stopper 134 is disposed within the first syringe barrel 110 at a first position to slidably seal and define the mixing chamber 130. The reciprocable stopper 134 may also be described as a grommet or slidable seal, and these terms may be used interchangeably.
The reciprocable stopper 134 has an outer side 135 facing the open end 116 of the first syringe barrel 110. The reciprocable stopper 134 also has an inner side 137 facing the delivery passage 114 of the first syringe barrel 110.
As best illustrated in FIGURE 16, the reciprocable stopper 134 is resilient and has a generally hollow central portion. The reciprocable stopper 134 has at least one longitudinal slit 141 through the body of the reciprocable stopper. The slit defines flaps or lips 142 which are biased to a normally closed position. When pressurized from the outer side 135 of the reciprocable stopper, the lips 142 can open at the inner side 137 of the reciprocable stopper toward the delivery passage 114 of the first syringe barrel. Preferably, the inner side 137 of the reciprocable stopper defines a generally conical surface when the slit 141 is closed.
The reciprocable stopper 134 has an enlarged receiving cavity 143 defined in the hollow central portion adjacent the lips 142 of the reciprocable stopper The reciprocable stopper 134 also has a smaller entrance passage 146 between the outer side 136 of the reciprocable stopper and the enlarged receiving cavity 143 so as to define a retention shoulder 148 around the smaller entrance passage 146.
With continued reference to FIGURE 16, the reciprocable stopper 134 is adapted to be mounted to the end of a sterility maintenance sleeve 150. The sterility maintenance sleeve 150 has an outlet end having an enlarged head 152 which is force-fit into the enlarged receiving cavity 143 of the resilient reciprocable stopper 134. The sterility maintenance sleeve 150 includes a reduced diameter neck 154 which is received in the smaller entrance passage 146 of the reciprocable stopper 134. A support flange 156 projects radially outwardly from the top of the neck 154 of the sterility maintenance sleeve adjacent the outer side 135 of the reciprocable stopper. The support flange 156 functions as a support which keeps the reciprocable stopper 134 from collapsing or otherwise excessively deforming in a manner that would permit undesirable fluid leakage.
As illustrated in FIGURES 10 and 16, the reciprocable stopper 134 preferably defines a clearance chamber or clearance space 157 between the lips 142 of the reciprocable stopper and the outlet end (bottom distal surface) of the enlarged head 152 of the sterility = maintenance sleeve. This clearance space insures that the resilient lips 142 will always be able to close tightly against each other, even in the absence of a pressure differential sufficient to open them as described in detail hereinafter.
The enlarged head 152 at the outlet end of the sterility maintenance sleeve 150 has an outlet passage 158 from which fluid can flow into the clearance space 157 between the enlarged head 152 of the sterility maintenance sleeve and the inside surface of the lips 142 of the reciprocable stopper 134. As illustrated in FIGURES 10 and 16, the upper end of the outlet passage 158 of the sterility maintenance sleeve communicates with the interior of a luer socket 160 which projects upwardly above the support flange 156 of the sterility maintenance sleeve.
The luer socket 160 is adapted to receive a luer nozzle of a diluent syringe as explained in detail hereinafter.
With continued reference to FIGURE 10, the sterility maintenance sleeve 150 has an enlarged diameter body portion 162 having an interior female thread 164. As illustrated in FIGURE 10, a removable plug 170 is provided for being initially inserted into the interior of the body portion 162 of the sterility maintenance sleeve 150. The plug 170 includes a nozzle-shaped distal end 172 for being received in the luer socket 160 of the sterility maintenance sleeve 150. The distal end 172 of the plug 170 is closed, however, so that there is no fluid passage from the plug 170 into the outlet passage 158 of the sterility maintenance sleeve.
The plug 170 also includes a cylindrical body portion 174 which has, at its lower end, a lug or engaging member 176 for threadingly engaging the interior, female thread 164 on the body portion 162 of the sterility maintenance sleeve 150. The upper end of the plug 170 includes an exterior seal ring or seal portion 178 for sealing the offset portion 121 of the interior surface 118 of the first syringe barrel 110 as described in detail hereinafter.
The first syringe barrel 110 has an open end 116 with a transverse flange 117. The first syringe barrel 110 is preferably cylindrical and preferably has a cylindrical interior surface 118.
When the removable closure 128 is properly secured to the first syringe barrel 110, the first syringe barrel 110 functions as a container defining an expandable mixing chamber 130 which can be filled with a predetermined quantity of a drug concentrate M which may be in a liquid or powder form. The concentrated drug M could be a lyophilized drug, for example.
A reciprocable stopper 134 is disposed within the first syringe barrel 110 at a first position to slidably seal and define the mixing chamber 130. The reciprocable stopper 134 may also be described as a grommet or slidable seal, and these terms may be used interchangeably.
The reciprocable stopper 134 has an outer side 135 facing the open end 116 of the first syringe barrel 110. The reciprocable stopper 134 also has an inner side 137 facing the delivery passage 114 of the first syringe barrel 110.
As best illustrated in FIGURE 16, the reciprocable stopper 134 is resilient and has a generally hollow central portion. The reciprocable stopper 134 has at least one longitudinal slit 141 through the body of the reciprocable stopper. The slit defines flaps or lips 142 which are biased to a normally closed position. When pressurized from the outer side 135 of the reciprocable stopper, the lips 142 can open at the inner side 137 of the reciprocable stopper toward the delivery passage 114 of the first syringe barrel. Preferably, the inner side 137 of the reciprocable stopper defines a generally conical surface when the slit 141 is closed.
The reciprocable stopper 134 has an enlarged receiving cavity 143 defined in the hollow central portion adjacent the lips 142 of the reciprocable stopper The reciprocable stopper 134 also has a smaller entrance passage 146 between the outer side 136 of the reciprocable stopper and the enlarged receiving cavity 143 so as to define a retention shoulder 148 around the smaller entrance passage 146.
With continued reference to FIGURE 16, the reciprocable stopper 134 is adapted to be mounted to the end of a sterility maintenance sleeve 150. The sterility maintenance sleeve 150 has an outlet end having an enlarged head 152 which is force-fit into the enlarged receiving cavity 143 of the resilient reciprocable stopper 134. The sterility maintenance sleeve 150 includes a reduced diameter neck 154 which is received in the smaller entrance passage 146 of the reciprocable stopper 134. A support flange 156 projects radially outwardly from the top of the neck 154 of the sterility maintenance sleeve adjacent the outer side 135 of the reciprocable stopper. The support flange 156 functions as a support which keeps the reciprocable stopper 134 from collapsing or otherwise excessively deforming in a manner that would permit undesirable fluid leakage.
As illustrated in FIGURES 10 and 16, the reciprocable stopper 134 preferably defines a clearance chamber or clearance space 157 between the lips 142 of the reciprocable stopper and the outlet end (bottom distal surface) of the enlarged head 152 of the sterility = maintenance sleeve. This clearance space insures that the resilient lips 142 will always be able to close tightly against each other, even in the absence of a pressure differential sufficient to open them as described in detail hereinafter.
The enlarged head 152 at the outlet end of the sterility maintenance sleeve 150 has an outlet passage 158 from which fluid can flow into the clearance space 157 between the enlarged head 152 of the sterility maintenance sleeve and the inside surface of the lips 142 of the reciprocable stopper 134. As illustrated in FIGURES 10 and 16, the upper end of the outlet passage 158 of the sterility maintenance sleeve communicates with the interior of a luer socket 160 which projects upwardly above the support flange 156 of the sterility maintenance sleeve.
The luer socket 160 is adapted to receive a luer nozzle of a diluent syringe as explained in detail hereinafter.
With continued reference to FIGURE 10, the sterility maintenance sleeve 150 has an enlarged diameter body portion 162 having an interior female thread 164. As illustrated in FIGURE 10, a removable plug 170 is provided for being initially inserted into the interior of the body portion 162 of the sterility maintenance sleeve 150. The plug 170 includes a nozzle-shaped distal end 172 for being received in the luer socket 160 of the sterility maintenance sleeve 150. The distal end 172 of the plug 170 is closed, however, so that there is no fluid passage from the plug 170 into the outlet passage 158 of the sterility maintenance sleeve.
The plug 170 also includes a cylindrical body portion 174 which has, at its lower end, a lug or engaging member 176 for threadingly engaging the interior, female thread 164 on the body portion 162 of the sterility maintenance sleeve 150. The upper end of the plug 170 includes an exterior seal ring or seal portion 178 for sealing the offset portion 121 of the interior surface 118 of the first syringe barrel 110 as described in detail hereinafter.
The plug 170 also includes a graspable portion 180.
Preferably, the graspable portion 180 has an enlarged cross section and has an exterior surface which can be easily grasped to rotate the plug 170 to unthread it from the sterility maintenance sleeve 150 as described in detail hereinafter.
The preferred embodiment of the syringe mixing system also includes a diluent syringe 182 as illustrated in FIGURE 11. The diluent syringe 182 includes a diluent syringe barrel 183 that holds a liquid diluent D. The lower portion of the diluent syringe barrel 183 has an exterior engaging member or lug 188 for engaging the interior thread 164 of the sterility maintenance sleeve as described in detail hereinafter. The diluent syringe barrel 183 has a discharge end 190 in the form of a luer nozzle defining a discharge passage 192. Preferably, a removable exterior closure 194 is provided for sealingly closing the discharge passage 192 of the diluent syringe. The removable closure 194 may employ a friction fit, or alternatively, a snap-fit or threaded connection may be employed.
The diluent syringe 182 also includes a plunger assembly including a movable piston 184 and a plunger stem 185. The movable piston 184 is slidably and sealingly disposed in the diluent syringe barrel 183 and is used for expressing the liquid diluent D out of the syringe barrel 183 through the discharge passage 192 in the well known manner.
The preferred embodiment of the syringe system illustrated in FIGURE 9 may bP provided to-t,he-user-as--GnA package -of -two -separate subassemblies. One subassembly is the prefilled and capped diluent syringe 182 as illustrated in FIGURE 11, and the other subassembly includes the remaining components fitted together as illustrated in FIGURE
10 with a drug M (which may be a lyophilized drug) in the first syringe barrel 110.
Preferably, the graspable portion 180 has an enlarged cross section and has an exterior surface which can be easily grasped to rotate the plug 170 to unthread it from the sterility maintenance sleeve 150 as described in detail hereinafter.
The preferred embodiment of the syringe mixing system also includes a diluent syringe 182 as illustrated in FIGURE 11. The diluent syringe 182 includes a diluent syringe barrel 183 that holds a liquid diluent D. The lower portion of the diluent syringe barrel 183 has an exterior engaging member or lug 188 for engaging the interior thread 164 of the sterility maintenance sleeve as described in detail hereinafter. The diluent syringe barrel 183 has a discharge end 190 in the form of a luer nozzle defining a discharge passage 192. Preferably, a removable exterior closure 194 is provided for sealingly closing the discharge passage 192 of the diluent syringe. The removable closure 194 may employ a friction fit, or alternatively, a snap-fit or threaded connection may be employed.
The diluent syringe 182 also includes a plunger assembly including a movable piston 184 and a plunger stem 185. The movable piston 184 is slidably and sealingly disposed in the diluent syringe barrel 183 and is used for expressing the liquid diluent D out of the syringe barrel 183 through the discharge passage 192 in the well known manner.
The preferred embodiment of the syringe system illustrated in FIGURE 9 may bP provided to-t,he-user-as--GnA package -of -two -separate subassemblies. One subassembly is the prefilled and capped diluent syringe 182 as illustrated in FIGURE 11, and the other subassembly includes the remaining components fitted together as illustrated in FIGURE
10 with a drug M (which may be a lyophilized drug) in the first syringe barrel 110.
Alternatively the drug subassembly illustrated in FIGURE 10 can be provided to the user in a separate single package. The diluent syringe 182 illustrated in FIGURE 11 can also be supplied separately and stored for later use. At the time of use, the plug 170 is removed from the inside of the sterility maintenance sleeve 150 of the first syringe barrel 110 by rotating the plug in the clockwise or counterclockwise direction to unthread the plug 170 from the sterility maintenance sleeve 150.
Preferably, the graspable portion 180 of the plug 170 has a knurled surface to accommodate the grasping of the plug between a person's thumb and fingers.
Next, the diluent syringe 182 (FIGURE 11) is prepared for insertion into the sterility maintenance sleeve 150 of the first syringe barrel 110. The diluent syringe 182 can be inverted and the cap 194 removed. The first syringe barrel 110 can also be inverted and aligned with the inverted diluent syringe barrel 183. Relative longitudinal movement can then be effected so as to telescopically insert the diluent syringe barrel 183 into the sterility maintenance sleeve 150 in the first syringe barrel 110. The lug 188 on the diluent syringe barrel 183 is threadingly engaged with the female thread form 164 of the sterility maintenance sleeve as shown in FIGURE 12. The diluent syringe barrel 183 is then threaded into the sterility maintenance sleeve 150 until the syringe barrel reaches the fully threaded position illustrated in FIGURE 12.
Referring now to FIGURE 13, the liquid diluent D in the diluent syringe barrel 183 is expressed into the mixing chamber 130 of the first syringe barrel 110 by pushing on the plunger stem 185 of the diluent syringe.
The slit 141 in the reciprocable stopper 134 opens under the increased pressure resulting from the movement of the movable piston =
184. The liquid diluent D is thus forced into the first mixing chamber 130 of the first syringe barrel as shown in FIGURES 13 and 14. The liquid diluent D is thereby mixed or combined with the drug M. If the drug M is a dry powder such as a lyophilized drug, the liquid diluent D will reconstitute the drug in solution form. As the liquid diluent D fills the mixing chamber 130 in the first syringe barrel 110, the volume of the mixing chamber 130 increases, and the reciprocable stopper 134 is forced to slide outwardly in the first syringe barrel. As the reciprocable stopper 134 slides outwardly, the sterility maintenance sleeve 150 and the diluent syringe assembly 182 inove outwardly with the reciprocable stopper 134.
The sterility maintenance sleeve 150 maintains the sterility of the interior surface 118 of the first syringe barrel 110 before and during the outward movement of the reciprocable stopper 134. Thus when the diluent is discharged from the second syringe barrel 183 into the mixing chamber 130 of the first syringe barrel, the expanding portion of the mixing chamber 130 has not been exposed to touch contamination. Thus the drug M and the diluent D are mixing in a sterile mixing chamber.
When all of the liquid diluent D has been expressed from the diluent syringe 182, the movable piston plunger 184 bottoms out in the diluent syringe barrel 183. Preferably, the upper, distal end of the plunger stem 185 has a radial flange 196, and the upper, distal end of the diluent syringe barrel 183 has a snap-fit type groove 198 for receiving and holding the radial flange 196 in a snap-fit engagement. The snap fit of the flange--196--and- g-roova--1-98 retains--the-r-~ovable piJtcyn 1847-the-pfurg-er stem 185 and the second syringe barrel 183 in a snapped-together condition. The snap fit prevents the movable piston 184 from being drawn outwardly from the diluent syringe barrel 183.
The snapped-together diluent syringe 182 together with the sterility maintenance sleeve 150 and the reciprocable stopper 134 can now function as the plunger and piston, respectively, of the primary administration syringe. In order to dispense the reconstituted drug solution MX, the assembled system shown in FIGURE 14 can first be shaken to insure good mixing and then inverted.
The closure 128 is then removed from the inverted assembly.
The snapped together and assembled plunger stem 185 and diluent syringe barrel 183 in conjunction with the reciprocable stopper 134 are then pushed to remove air from ( i.e. prime ) the first syringe barrel 110 through the nozzle 102. The nozzle 102 may then be connected to an appropriate connector of an administration set or other conduit. Then the snapped together diluent syringe assembly 182 and the reciprocable stopper 134 are pushed further inwardly to express the drug solution MX
out of the first syringe barrel 110 (FIGURE 15). The hydraulic pressure of the drug solution in the first syringe barrel 110 forces the slit 141 in the reciprocable stopper to close (if it has not already closed) and to remain closed. The support flange 156 on the sterility maintenance sleeve 150 prevents undue deformation of the reciprocable stopper 134. The flange thus prevents leakage around the reciprocable stopper 134 between the reciprocable stopper 134 and the interior surface 118 of the first syringe barrel 110. Furthermore, the clearance space 157 between the enlarged head 152 at the lower end of the sterility maintenance sleeve 150 and the inside surface of the lips 142 of the reciprocable stopper permits the lips 142 on each side of the slit 141 to fully close.
In an alternative operation of the drug delivery system of the present invention, it will be appreciated that in all of the illustrated embodiments, the diluent D from the second syringe assembly 182 can be caused to flow into the first syringe barrel 110 from the second syringe barrel by pulling the two barrels (i.e. first barrel 110 and second barrel 183 in FIGURE 13 for example) outwardly relative to each other. This will create a pressure differential as the mixing chamber 130 expands, which WO 96/29106 PCTlUS96/03913 will move ( i.e. pull or draw ) the diluent D in the second syringe barrel into the mixing chamber 130 of the first syringe barrel.
From the foregoing, it will be observed that numerous modifications and variations can be effected without departing from the true spirit and scope of the novel concept of the present invention. It is to be understood that no limitation with respect to the specific embodiments of the present disclosure herein is intended or should be inferred. The disclosure is intended to cover, by the appended claims, all such modifications as fall within the scope of the claims.
Preferably, the graspable portion 180 of the plug 170 has a knurled surface to accommodate the grasping of the plug between a person's thumb and fingers.
Next, the diluent syringe 182 (FIGURE 11) is prepared for insertion into the sterility maintenance sleeve 150 of the first syringe barrel 110. The diluent syringe 182 can be inverted and the cap 194 removed. The first syringe barrel 110 can also be inverted and aligned with the inverted diluent syringe barrel 183. Relative longitudinal movement can then be effected so as to telescopically insert the diluent syringe barrel 183 into the sterility maintenance sleeve 150 in the first syringe barrel 110. The lug 188 on the diluent syringe barrel 183 is threadingly engaged with the female thread form 164 of the sterility maintenance sleeve as shown in FIGURE 12. The diluent syringe barrel 183 is then threaded into the sterility maintenance sleeve 150 until the syringe barrel reaches the fully threaded position illustrated in FIGURE 12.
Referring now to FIGURE 13, the liquid diluent D in the diluent syringe barrel 183 is expressed into the mixing chamber 130 of the first syringe barrel 110 by pushing on the plunger stem 185 of the diluent syringe.
The slit 141 in the reciprocable stopper 134 opens under the increased pressure resulting from the movement of the movable piston =
184. The liquid diluent D is thus forced into the first mixing chamber 130 of the first syringe barrel as shown in FIGURES 13 and 14. The liquid diluent D is thereby mixed or combined with the drug M. If the drug M is a dry powder such as a lyophilized drug, the liquid diluent D will reconstitute the drug in solution form. As the liquid diluent D fills the mixing chamber 130 in the first syringe barrel 110, the volume of the mixing chamber 130 increases, and the reciprocable stopper 134 is forced to slide outwardly in the first syringe barrel. As the reciprocable stopper 134 slides outwardly, the sterility maintenance sleeve 150 and the diluent syringe assembly 182 inove outwardly with the reciprocable stopper 134.
The sterility maintenance sleeve 150 maintains the sterility of the interior surface 118 of the first syringe barrel 110 before and during the outward movement of the reciprocable stopper 134. Thus when the diluent is discharged from the second syringe barrel 183 into the mixing chamber 130 of the first syringe barrel, the expanding portion of the mixing chamber 130 has not been exposed to touch contamination. Thus the drug M and the diluent D are mixing in a sterile mixing chamber.
When all of the liquid diluent D has been expressed from the diluent syringe 182, the movable piston plunger 184 bottoms out in the diluent syringe barrel 183. Preferably, the upper, distal end of the plunger stem 185 has a radial flange 196, and the upper, distal end of the diluent syringe barrel 183 has a snap-fit type groove 198 for receiving and holding the radial flange 196 in a snap-fit engagement. The snap fit of the flange--196--and- g-roova--1-98 retains--the-r-~ovable piJtcyn 1847-the-pfurg-er stem 185 and the second syringe barrel 183 in a snapped-together condition. The snap fit prevents the movable piston 184 from being drawn outwardly from the diluent syringe barrel 183.
The snapped-together diluent syringe 182 together with the sterility maintenance sleeve 150 and the reciprocable stopper 134 can now function as the plunger and piston, respectively, of the primary administration syringe. In order to dispense the reconstituted drug solution MX, the assembled system shown in FIGURE 14 can first be shaken to insure good mixing and then inverted.
The closure 128 is then removed from the inverted assembly.
The snapped together and assembled plunger stem 185 and diluent syringe barrel 183 in conjunction with the reciprocable stopper 134 are then pushed to remove air from ( i.e. prime ) the first syringe barrel 110 through the nozzle 102. The nozzle 102 may then be connected to an appropriate connector of an administration set or other conduit. Then the snapped together diluent syringe assembly 182 and the reciprocable stopper 134 are pushed further inwardly to express the drug solution MX
out of the first syringe barrel 110 (FIGURE 15). The hydraulic pressure of the drug solution in the first syringe barrel 110 forces the slit 141 in the reciprocable stopper to close (if it has not already closed) and to remain closed. The support flange 156 on the sterility maintenance sleeve 150 prevents undue deformation of the reciprocable stopper 134. The flange thus prevents leakage around the reciprocable stopper 134 between the reciprocable stopper 134 and the interior surface 118 of the first syringe barrel 110. Furthermore, the clearance space 157 between the enlarged head 152 at the lower end of the sterility maintenance sleeve 150 and the inside surface of the lips 142 of the reciprocable stopper permits the lips 142 on each side of the slit 141 to fully close.
In an alternative operation of the drug delivery system of the present invention, it will be appreciated that in all of the illustrated embodiments, the diluent D from the second syringe assembly 182 can be caused to flow into the first syringe barrel 110 from the second syringe barrel by pulling the two barrels (i.e. first barrel 110 and second barrel 183 in FIGURE 13 for example) outwardly relative to each other. This will create a pressure differential as the mixing chamber 130 expands, which WO 96/29106 PCTlUS96/03913 will move ( i.e. pull or draw ) the diluent D in the second syringe barrel into the mixing chamber 130 of the first syringe barrel.
From the foregoing, it will be observed that numerous modifications and variations can be effected without departing from the true spirit and scope of the novel concept of the present invention. It is to be understood that no limitation with respect to the specific embodiments of the present disclosure herein is intended or should be inferred. The disclosure is intended to cover, by the appended claims, all such modifications as fall within the scope of the claims.
Claims (15)
1. A drug delivery system, comprising:
a first pre-filled syringe assembly comprising:
a first syringe barrel having an interior surface, an open end, and an opposite delivery end which defines a drug delivery passage;
a reciprocable stopper slidably disposed within said first syringe barrel in sealing engagement therewith for defining an internal mixing chamber within said first syringe barrel in communication with said delivery passage; and a sterility maintenance sleeve extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance sleeve maintaining the sterility of the interior surface of said first syringe barrel;
a second pre-filled syringe assembly comprising:
a second syringe barrel having a fluid discharge passage at one end thereof, said second syringe barrel being sized to be disposed within the sterility maintenance sleeve of said first syringe assembly;
a movable piston plunger positionable within said second syringe barrel to define a fluid chamber therewith in communication with said fluid discharge passage;
and a liquid in the fluid chamber of said second syringe barrel; and said system further including fluid transfer connector means for providing fluid communication from the fluid chamber of said second syringe assembly to said internal mixing chamber of said first syringe assembly when said second syringe assembly is disposed within said sterility maintenance sleeve so that the liquid within said fluid chamber can be caused to flow through said fluid transfer connector means into said internal mixing chamber of said first syringe assembly by movement of said piston plunger toward said fluid discharge passage of said second syringe assembly and thereafter caused to flow from said mixing chamber of said first syringe assembly through said drug delivery passage by movement of said second syringe assembly together with said reciprocable stopper and said sterility maintenance sleeve toward the drug delivery passage of said first syringe assembly, said fluid transfer connector means includes means for regulating the flow of fluid through said reciprocable stopper, said reciprocable stopper has an outer side facing toward said open end of said first syringe barrel and an inner side facing toward said drug delivery passage, said means for regulating the flow of fluid through said reciprocable stopper comprises said reciprocable stopper having a resilient body with a longitudinal slit through the resilient body defining two normally closed resilient lips, and the resilient body of said reciprocable stopper is substantially hollow and includes an enlarged cavity and a smaller entrance passage; and said sterility maintenance sleeve further includes:
an enlarged head for being received in said enlarged cavity un said enlarged cavity of said resilient body, a smaller neck for being received in said smaller entrance passage of said resilient body, and a radially extending support flange adjacent said smaller neck for axially supporting said reciprocable stopper outer side.
a first pre-filled syringe assembly comprising:
a first syringe barrel having an interior surface, an open end, and an opposite delivery end which defines a drug delivery passage;
a reciprocable stopper slidably disposed within said first syringe barrel in sealing engagement therewith for defining an internal mixing chamber within said first syringe barrel in communication with said delivery passage; and a sterility maintenance sleeve extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance sleeve maintaining the sterility of the interior surface of said first syringe barrel;
a second pre-filled syringe assembly comprising:
a second syringe barrel having a fluid discharge passage at one end thereof, said second syringe barrel being sized to be disposed within the sterility maintenance sleeve of said first syringe assembly;
a movable piston plunger positionable within said second syringe barrel to define a fluid chamber therewith in communication with said fluid discharge passage;
and a liquid in the fluid chamber of said second syringe barrel; and said system further including fluid transfer connector means for providing fluid communication from the fluid chamber of said second syringe assembly to said internal mixing chamber of said first syringe assembly when said second syringe assembly is disposed within said sterility maintenance sleeve so that the liquid within said fluid chamber can be caused to flow through said fluid transfer connector means into said internal mixing chamber of said first syringe assembly by movement of said piston plunger toward said fluid discharge passage of said second syringe assembly and thereafter caused to flow from said mixing chamber of said first syringe assembly through said drug delivery passage by movement of said second syringe assembly together with said reciprocable stopper and said sterility maintenance sleeve toward the drug delivery passage of said first syringe assembly, said fluid transfer connector means includes means for regulating the flow of fluid through said reciprocable stopper, said reciprocable stopper has an outer side facing toward said open end of said first syringe barrel and an inner side facing toward said drug delivery passage, said means for regulating the flow of fluid through said reciprocable stopper comprises said reciprocable stopper having a resilient body with a longitudinal slit through the resilient body defining two normally closed resilient lips, and the resilient body of said reciprocable stopper is substantially hollow and includes an enlarged cavity and a smaller entrance passage; and said sterility maintenance sleeve further includes:
an enlarged head for being received in said enlarged cavity un said enlarged cavity of said resilient body, a smaller neck for being received in said smaller entrance passage of said resilient body, and a radially extending support flange adjacent said smaller neck for axially supporting said reciprocable stopper outer side.
2. A drug delivery system in accordance with claim 1, wherein said fluid transfer connector means further includes a fluid passageway through said enlarged head, smaller neck, and radial support flange of said sterility maintenance sleeve.
3. A drug delivery system in accordance with claim 2 wherein said inner side of said reciprocable stopper defines a conical surface tapering to an apex and said longitudinal slit is at the apex; and a clearance space is defined between said enlarged head of the sterility maintenance sleeve and said longitudinal slit when said lips are closed.
4. A drug delivery system, comprising:
a first pre-filled syringe assembly comprising:
a first syringe barrel having an interior surface, an open end, and an opposite delivery end which defines a drug delivery passage;
a reciprocable stopper slidably disposed within said first syringe barrel in sealing engagement therewith for defining an internal mixing chamber within said first syringe barrel in communication with said delivery passage; and a sterility maintenance sleeve extending from said reciprocable stopper toward said open end of said first syringe barrel said sterility maintenance sleeve maintaining the sterility of the interior surface of said first syringe barrel;
a second pre-filled syringe assembly comprising:
a second syringe barrel having a fluid discharge passage at one end thereof, said second syringe barrel being sized to be disposed within the sterility maintenance sleeve of said first syringe assembly;
a movable piston plunger positionable within said second syringe barrel to define a fluid chamber therewith in communication with said fluid discharge passage;
and a liquid in the fluid chamber of said second syringe barrel; and said system further including fluid transfer connector means for providing fluid communication from the fluid chamber of said second syringe assembly to said internal mixing chamber of said first syringe assembly when said second syringe assembly is disposed within said sterility maintenance sleeve so that the liquid within said fluid chamber can be caused to flow through said fluid transfer connector means into said internal mixing chamber of said first syringe assembly by movement of said piston plunger toward said fluid discharge passage of said second syringe assembly and thereafter caused to flow from said mixing chamber of said first syringe assembly through said drug delivery passage by movement of said second syringe assembly together with said reciprocable stopper and said sterility maintenance sleeve toward the drug delivery passage of said first syringe assembly, said fluid transfer connector means includes means for regulating the flow of fluid through said reciprocable stopper, said means for regulating the flow of fluid through said reciprocable stopper comprises a normally closed, pressure actuatable valve, and said second syringe assembly and said sterility maintenance sleeve define means for engaging which comprises:
a luer nozzle at said fluid discharge passage of said second syringe assembly, and a cooperating luer socket in said sterility maintenance sleeve.
a first pre-filled syringe assembly comprising:
a first syringe barrel having an interior surface, an open end, and an opposite delivery end which defines a drug delivery passage;
a reciprocable stopper slidably disposed within said first syringe barrel in sealing engagement therewith for defining an internal mixing chamber within said first syringe barrel in communication with said delivery passage; and a sterility maintenance sleeve extending from said reciprocable stopper toward said open end of said first syringe barrel said sterility maintenance sleeve maintaining the sterility of the interior surface of said first syringe barrel;
a second pre-filled syringe assembly comprising:
a second syringe barrel having a fluid discharge passage at one end thereof, said second syringe barrel being sized to be disposed within the sterility maintenance sleeve of said first syringe assembly;
a movable piston plunger positionable within said second syringe barrel to define a fluid chamber therewith in communication with said fluid discharge passage;
and a liquid in the fluid chamber of said second syringe barrel; and said system further including fluid transfer connector means for providing fluid communication from the fluid chamber of said second syringe assembly to said internal mixing chamber of said first syringe assembly when said second syringe assembly is disposed within said sterility maintenance sleeve so that the liquid within said fluid chamber can be caused to flow through said fluid transfer connector means into said internal mixing chamber of said first syringe assembly by movement of said piston plunger toward said fluid discharge passage of said second syringe assembly and thereafter caused to flow from said mixing chamber of said first syringe assembly through said drug delivery passage by movement of said second syringe assembly together with said reciprocable stopper and said sterility maintenance sleeve toward the drug delivery passage of said first syringe assembly, said fluid transfer connector means includes means for regulating the flow of fluid through said reciprocable stopper, said means for regulating the flow of fluid through said reciprocable stopper comprises a normally closed, pressure actuatable valve, and said second syringe assembly and said sterility maintenance sleeve define means for engaging which comprises:
a luer nozzle at said fluid discharge passage of said second syringe assembly, and a cooperating luer socket in said sterility maintenance sleeve.
5. A drug delivery system in accordance with claim 4, wherein said means for engaging further includes means for threadable connection on said second syringe assembly, and cooperating means for threadable connection associated with the sterility maintenance sleeve of said first syringe assembly.
6. A drug delivery system in accordance with claim 5, wherein said threadable connection means extends radially from said second syringe barrel, and said cooperating threadable connection means is a thread form in said sterility maintenance sleeve.
7. A drug delivery system in accordance with claim 6, wherein said second syringe assembly further includes locking means for locking said movable piston plunger against movement in said second syringe barrel after movement of said piston plunger causes said liquid to flow from said fluid chamber into said internal mixing chamber of said first syringe assembly.
8. A syringe system comprising:
a first syringe assembly including a first barrel having an interior surface, an open end, and a delivery end defining a delivery passage to accommodate the delivery of a fluid mixture from said first barrel;
a reciprocable stopper slidably disposed in said first barrel and defining a mixing chamber between said delivery end of said first barrel and said reciprocable stopper;
a sterility maintenance member connected to and extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance member maintaining the sterility of the interior surface of said first syringe barrel; and a first constituent in said mixing chamber;
a second syringe assembly including a second barrel that is sized to be disposed in said sterility maintenance member and that has a discharge end defining a discharge passage communicating through said discharge end to accommodate the discharge of fluid from said second barrel;
a moveable piston plunger slidably disposed within said second barrel and defining a second chamber between said discharge end and said piston plunger;
and a liquid second constituent in said second chamber; wherein said reciprocable stopper and sterility maintenance member are engageable to cooperatively define a coupling means accommodating the flow of said liquid second constituent from said second syringe barrel into said mixing chamber as said second syringe assembly, together with the engaged sterility maintenance sleeve and reciprocable stopper move outwardly relative to said mixing chamber, said coupling means includes means for controlling fluid flow from said second chamber into said first chamber, said fluid flow controlling means includes a one-way pressure actuatable valve biased to a normally closed position.
said reciprocable stopper is made of a resilient material and has an inner side which conically tapers to an apex toward said first chamber and includes a reduced thickness portion at the apex of the conical shape with at least one slit through the apex into the first chamber to define said one-way pressure actuatable valve, said at least one slit defines opposed lips in said reciprocable stopper which are caused to resiliently open into said first chamber by fluid pressure from said second chamber, said reciprocable stopper further includes an outer side facing toward said first syringe barrel open end, said reciprocable stopper having an enlarged receiving cavity and a smaller entrance passage extending from said outer side to said enlarged cavity whereby the opening of said lips establishes communication from said enlarged cavity through said reciprocable stopper into said first chamber and whereby said lips are normally biased to a closed position, said sterility maintenance member includes a generally cylindrical sleeve; and said coupling means further includes a support structure on said sterility maintenance member, said support structure including an enlarged head and an adjacent smaller neck, said enlarged head being sealingly engaged with said enlarged receiving cavity of said reciprocable stopper and said smaller neck extending through said entrance passage of said reciprocable stopper, said sterility maintenance sleeve support structure defining a central passageway through said enlarged head and smaller neck whereby said central passageway is normally occluded by said closed lips.
a first syringe assembly including a first barrel having an interior surface, an open end, and a delivery end defining a delivery passage to accommodate the delivery of a fluid mixture from said first barrel;
a reciprocable stopper slidably disposed in said first barrel and defining a mixing chamber between said delivery end of said first barrel and said reciprocable stopper;
a sterility maintenance member connected to and extending from said reciprocable stopper toward said open end of said first syringe barrel, said sterility maintenance member maintaining the sterility of the interior surface of said first syringe barrel; and a first constituent in said mixing chamber;
a second syringe assembly including a second barrel that is sized to be disposed in said sterility maintenance member and that has a discharge end defining a discharge passage communicating through said discharge end to accommodate the discharge of fluid from said second barrel;
a moveable piston plunger slidably disposed within said second barrel and defining a second chamber between said discharge end and said piston plunger;
and a liquid second constituent in said second chamber; wherein said reciprocable stopper and sterility maintenance member are engageable to cooperatively define a coupling means accommodating the flow of said liquid second constituent from said second syringe barrel into said mixing chamber as said second syringe assembly, together with the engaged sterility maintenance sleeve and reciprocable stopper move outwardly relative to said mixing chamber, said coupling means includes means for controlling fluid flow from said second chamber into said first chamber, said fluid flow controlling means includes a one-way pressure actuatable valve biased to a normally closed position.
said reciprocable stopper is made of a resilient material and has an inner side which conically tapers to an apex toward said first chamber and includes a reduced thickness portion at the apex of the conical shape with at least one slit through the apex into the first chamber to define said one-way pressure actuatable valve, said at least one slit defines opposed lips in said reciprocable stopper which are caused to resiliently open into said first chamber by fluid pressure from said second chamber, said reciprocable stopper further includes an outer side facing toward said first syringe barrel open end, said reciprocable stopper having an enlarged receiving cavity and a smaller entrance passage extending from said outer side to said enlarged cavity whereby the opening of said lips establishes communication from said enlarged cavity through said reciprocable stopper into said first chamber and whereby said lips are normally biased to a closed position, said sterility maintenance member includes a generally cylindrical sleeve; and said coupling means further includes a support structure on said sterility maintenance member, said support structure including an enlarged head and an adjacent smaller neck, said enlarged head being sealingly engaged with said enlarged receiving cavity of said reciprocable stopper and said smaller neck extending through said entrance passage of said reciprocable stopper, said sterility maintenance sleeve support structure defining a central passageway through said enlarged head and smaller neck whereby said central passageway is normally occluded by said closed lips.
9. The syringe system in accordance with claim 8 wherein said sterility maintenance sleeve support structure further comprises a radial flange adjacent said smaller neck for axially supporting said outer side of said reciprocable stopper.
10. The syringe system in accordance with claim 9 wherein said coupling means further includes:
a male luer nozzle disposed at said discharge end of said second barrel in fluid communication with said discharge passage; and a female luer socket in fluid communication with said central passageway through said sterility maintenance sleeve support structure, said male luer nozzle being insertable into said female luer socket as said second barrel is disposed within the sterility maintenance sleeve of the first barrel so that said one-way valve controls fluid flow between said second chamber and said first chamber.
a male luer nozzle disposed at said discharge end of said second barrel in fluid communication with said discharge passage; and a female luer socket in fluid communication with said central passageway through said sterility maintenance sleeve support structure, said male luer nozzle being insertable into said female luer socket as said second barrel is disposed within the sterility maintenance sleeve of the first barrel so that said one-way valve controls fluid flow between said second chamber and said first chamber.
11. The syringe system in accordance with claim 9 wherein said sterility maintenance sleeve support structure further includes engaging means; and said second syringe barrel further includes cooperating engaging means so that said second barrel is engageable with said sterility maintenance sleeve support structure on said reciprocable stopper.
12. The syringe system in accordance with claim 11 wherein said engaging means comprise a thread form on said sterility maintenance sleeve support structure; and said cooperating engaging means comprise a threadable flange on said second syringe barrel discharge end for threadingly engaging said sterility maintenance sleeve support structure thread form whereby a fluid tight connection is established between said discharge end of said second syringe barrel and said first syringe assembly.
13. The syringe system in accordance with claim 8, further including a first removable closure occluding said first barrel delivery passage;
a second removable closure occluding said second barrel discharge passage; and a cover removably mounted to said first barrel opposite said delivery end.
a second removable closure occluding said second barrel discharge passage; and a cover removably mounted to said first barrel opposite said delivery end.
14. The syringe system in accordance with claim 8 wherein said reciprocable stopper is a resilient elastomeric material.
15. The syringe system in accordance with claim 8 further including a plug for sealing said open end of said first barrel outwardly of said sterility maintenance member.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40843695A | 1995-03-22 | 1995-03-22 | |
US408,436 | 1995-03-22 | ||
US08/616,798 US5785682A (en) | 1995-03-22 | 1996-03-15 | Pre-filled syringe drug delivery system |
US616,798 | 1996-03-15 | ||
PCT/US1996/003913 WO1996029106A2 (en) | 1995-03-22 | 1996-03-21 | Pre-filled syringe drug delivery system |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2215912A1 CA2215912A1 (en) | 1996-09-26 |
CA2215912C true CA2215912C (en) | 2007-05-29 |
Family
ID=27020273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002215912A Expired - Fee Related CA2215912C (en) | 1995-03-22 | 1996-03-21 | Pre-filled syringe drug delivery system |
Country Status (11)
Country | Link |
---|---|
US (1) | US5785682A (en) |
EP (1) | EP0817654B1 (en) |
JP (1) | JP3803933B2 (en) |
AT (1) | ATE222784T1 (en) |
AU (1) | AU696759B2 (en) |
CA (1) | CA2215912C (en) |
DE (1) | DE69623268T2 (en) |
DK (1) | DK0817654T3 (en) |
ES (1) | ES2184856T3 (en) |
PT (1) | PT817654E (en) |
WO (1) | WO1996029106A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109890436A (en) * | 2016-11-01 | 2019-06-14 | 赛诺菲-安万特德国有限公司 | Feedback mechanism for injection device |
Families Citing this family (144)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876372A (en) * | 1995-03-22 | 1999-03-02 | Abbott Laboratories | Syringe system accomodating seperate prefilled barrels for two constituents |
AU738397B2 (en) * | 1995-03-29 | 2001-09-20 | Abbott Laboratories | Syringe system accommodating separate prefilled barrels for two constituents |
WO1998013088A1 (en) * | 1996-09-27 | 1998-04-02 | Abbott Laboratories | Syringe system accommodating separate prefilled barrels for two constituents |
US6149626A (en) * | 1997-10-03 | 2000-11-21 | Bachynsky; Nicholas | Automatic injecting syringe apparatus |
US6641565B1 (en) | 1998-11-13 | 2003-11-04 | Elan Pharma International Limited | drug delivery systems and methods |
WO2000047115A1 (en) * | 1999-02-10 | 2000-08-17 | Sub-Q, Inc. | Device and method for facilitating hemostasis of a biopsy tract |
US6562002B1 (en) * | 1999-02-16 | 2003-05-13 | Prismedical Corporation | Single dose delivery device |
EP1107806A1 (en) * | 1999-06-30 | 2001-06-20 | Baxter International Inc. | Syringe for transfer of medication from a prefilled medication container |
JP2001112867A (en) * | 1999-10-18 | 2001-04-24 | Terumo Corp | Syringe containing drug |
CA2400937C (en) * | 2000-02-23 | 2009-04-21 | Abbott Laboratories | Syringes and syringe systems for selectively dispensing controlled amounts of a therapeutic substance |
US6740062B2 (en) * | 2000-05-22 | 2004-05-25 | Pharmacia Ab | Medical device |
SE0001894D0 (en) * | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | Medical device |
US6432089B1 (en) * | 2000-06-21 | 2002-08-13 | Medrad, Inc. | Medical syringe |
AUPQ867900A0 (en) | 2000-07-10 | 2000-08-03 | Medrad, Inc. | Medical injector system |
DE10044545A1 (en) * | 2000-09-05 | 2002-04-04 | Roland Bodmeier | Retardpartikeldispersion |
US6511459B1 (en) * | 2000-09-29 | 2003-01-28 | Mallinckrodt Inc. | Syringe plunger having an improved sealing ability |
CA2448696A1 (en) * | 2001-05-04 | 2002-11-14 | Prismedical Corporation | Dual chamber dissolution container with passive agitation |
US20030032935A1 (en) * | 2001-08-10 | 2003-02-13 | Scimed Life Systems, Inc. | Packages facilitating convenient mixing and delivery of liquids |
US9226876B2 (en) | 2001-10-19 | 2016-01-05 | The Goodyear Tire & Rubber Company | Rubber for baby bottle nipples, pacifiers, and syringe plungers |
US6871751B2 (en) * | 2001-10-19 | 2005-03-29 | The Goodyear Tire & Rubber Company | Rubber for baby bottle nipples, pacifiers, & syringe plungers |
JP4152104B2 (en) * | 2001-12-28 | 2008-09-17 | テルモ株式会社 | Syringe and gasket |
US7462366B2 (en) | 2002-03-29 | 2008-12-09 | Boston Scientific Scimed, Inc. | Drug delivery particle |
AU2003240000A1 (en) | 2002-06-12 | 2003-12-31 | Boston Scientific Limited | Bulking agents |
GB0217285D0 (en) | 2002-07-25 | 2002-09-04 | Cambridge Consultants | Syringes |
US7842377B2 (en) | 2003-08-08 | 2010-11-30 | Boston Scientific Scimed, Inc. | Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
US8012454B2 (en) | 2002-08-30 | 2011-09-06 | Boston Scientific Scimed, Inc. | Embolization |
US7135027B2 (en) * | 2002-10-04 | 2006-11-14 | Baxter International, Inc. | Devices and methods for mixing and extruding medically useful compositions |
US7883490B2 (en) | 2002-10-23 | 2011-02-08 | Boston Scientific Scimed, Inc. | Mixing and delivery of therapeutic compositions |
FR2847887A1 (en) * | 2002-12-02 | 2004-06-04 | Valois Sas | Container for two fluid products to be mixed before dispensing has two receptacles separated by sliding plugs |
EP2314259B1 (en) | 2003-03-14 | 2015-07-29 | Depuy Spine, Inc. | Hydraulic device for injection of bone cement in percutaneous vertebroplasty |
US8066713B2 (en) | 2003-03-31 | 2011-11-29 | Depuy Spine, Inc. | Remotely-activated vertebroplasty injection device |
WO2006011152A2 (en) | 2004-06-17 | 2006-02-02 | Disc-O-Tech Medical Technologies, Ltd. | Methods for treating bone and other tissue |
US8415407B2 (en) | 2004-03-21 | 2013-04-09 | Depuy Spine, Inc. | Methods, materials, and apparatus for treating bone and other tissue |
US20050027255A1 (en) * | 2003-07-31 | 2005-02-03 | Sid Technologies, Llc | Automatic injector |
US7976823B2 (en) | 2003-08-29 | 2011-07-12 | Boston Scientific Scimed, Inc. | Ferromagnetic particles and methods |
US8579908B2 (en) | 2003-09-26 | 2013-11-12 | DePuy Synthes Products, LLC. | Device for delivering viscous material |
US7666169B2 (en) | 2003-11-25 | 2010-02-23 | Medrad, Inc. | Syringe and syringe plungers for use with medical injectors |
US7736671B2 (en) | 2004-03-02 | 2010-06-15 | Boston Scientific Scimed, Inc. | Embolization |
US8173176B2 (en) | 2004-03-30 | 2012-05-08 | Boston Scientific Scimed, Inc. | Embolization |
US6997910B2 (en) * | 2004-05-03 | 2006-02-14 | Infusive Technologies, Llc | Multi-chamber, sequential dose dispensing syringe |
US7998106B2 (en) | 2004-05-03 | 2011-08-16 | Thorne Jr Gale H | Safety dispensing system for hazardous substances |
US7101354B2 (en) * | 2004-05-03 | 2006-09-05 | Infusive Technologies, Llc | Mixing syringe with and without flush |
US7311861B2 (en) | 2004-06-01 | 2007-12-25 | Boston Scientific Scimed, Inc. | Embolization |
US7294119B2 (en) * | 2004-06-10 | 2007-11-13 | Safety Syringes, Inc. | Passive delivery system diluents mixing and delivery |
AT500930B1 (en) * | 2004-10-25 | 2007-03-15 | Pharma Consult Ges M B H & Co | METHOD AND DEVICE FOR LYOPHILIZING, RECONSTITUTING AND DISTRIBUTING A RECONSTITUTED ACTIVE SUBSTANCE |
US8425550B2 (en) | 2004-12-01 | 2013-04-23 | Boston Scientific Scimed, Inc. | Embolic coils |
WO2006058435A2 (en) * | 2004-12-03 | 2006-06-08 | Duoject Medical Systems Inc. | Cartridge, device and method for pharmaceutical storage, mixing and delivery |
WO2006066336A1 (en) * | 2004-12-24 | 2006-06-29 | Moore, Ian, Marshall | Safety syringe |
US7959600B2 (en) | 2004-12-30 | 2011-06-14 | Byeong S. Chang | Container closure delivery system |
US20060157507A1 (en) * | 2004-12-30 | 2006-07-20 | Chang Byeong S | Multi-functional container closure delivery system |
US7727555B2 (en) | 2005-03-02 | 2010-06-01 | Boston Scientific Scimed, Inc. | Particles |
US7858183B2 (en) | 2005-03-02 | 2010-12-28 | Boston Scientific Scimed, Inc. | Particles |
US7963287B2 (en) | 2005-04-28 | 2011-06-21 | Boston Scientific Scimed, Inc. | Tissue-treatment methods |
US20080208137A1 (en) * | 2005-05-16 | 2008-08-28 | Fago Frank M | Multi-Stage Sryinge and Methods of Using the Same |
GB2426931A (en) * | 2005-06-10 | 2006-12-13 | Pa Knowledge Ltd | Injection device |
US9463426B2 (en) | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
US9918767B2 (en) | 2005-08-01 | 2018-03-20 | DePuy Synthes Products, Inc. | Temperature control system |
US8007509B2 (en) | 2005-10-12 | 2011-08-30 | Boston Scientific Scimed, Inc. | Coil assemblies, components and methods |
US8360629B2 (en) | 2005-11-22 | 2013-01-29 | Depuy Spine, Inc. | Mixing apparatus having central and planetary mixing elements |
US8152839B2 (en) | 2005-12-19 | 2012-04-10 | Boston Scientific Scimed, Inc. | Embolic coils |
US8101197B2 (en) | 2005-12-19 | 2012-01-24 | Stryker Corporation | Forming coils |
US7947368B2 (en) | 2005-12-21 | 2011-05-24 | Boston Scientific Scimed, Inc. | Block copolymer particles |
KR100738100B1 (en) * | 2006-01-19 | 2007-07-12 | 삼성전자주식회사 | Device and method for pre-treatment and injection of liquid specimen |
US8926569B2 (en) | 2006-03-15 | 2015-01-06 | Bayer Medical Care Inc. | Plunger covers and plungers for use in syringes and methods of fabricating plunger covers and plungers for use in syringes |
ES2608284T3 (en) | 2006-05-25 | 2017-04-07 | Bayer Healthcare Llc | Reconstitution device |
WO2008032322A2 (en) | 2006-09-14 | 2008-03-20 | Depuy Spine, Inc. | Bone cement and methods of use thereof |
AU2015200078A1 (en) * | 2006-10-19 | 2015-02-05 | Depuy Spine, Inc. | Fluid delivery system |
WO2008047371A2 (en) * | 2006-10-19 | 2008-04-24 | Depuy Spine, Inc. | Fluid delivery system |
US8414927B2 (en) | 2006-11-03 | 2013-04-09 | Boston Scientific Scimed, Inc. | Cross-linked polymer particles |
USD847985S1 (en) | 2007-03-14 | 2019-05-07 | Bayer Healthcare Llc | Syringe plunger cover |
USD1002840S1 (en) | 2007-03-14 | 2023-10-24 | Bayer Healthcare Llc | Syringe plunger |
USD942005S1 (en) | 2007-03-14 | 2022-01-25 | Bayer Healthcare Llc | Orange syringe plunger cover |
US9044378B2 (en) | 2007-05-31 | 2015-06-02 | Safety Syringes, Inc. | Anti-needle stick safety device or system for use with drugs requiring reconstitution |
CN101925373A (en) * | 2008-01-23 | 2010-12-22 | 马林克罗特公司 | The plunger adapter that is used for coaxial syringe system |
WO2009102720A1 (en) * | 2008-02-11 | 2009-08-20 | Safety Syringes, Inc. | Reconstitution means for safety device |
US9107668B2 (en) * | 2008-03-25 | 2015-08-18 | Cook Medical Technologies Llc | Embolic particle mixing syringe |
WO2009140511A1 (en) | 2008-05-14 | 2009-11-19 | J&J Solutions, Inc. | Systems and methods for safe medicament transport |
EP2280751B1 (en) * | 2008-05-14 | 2021-12-01 | Biolyph, Llc | Reagent mixture preparation and dispensing devices and methods for the same |
CA2730967C (en) * | 2008-07-18 | 2017-01-03 | Becton, Dickinson And Company | Cartridge stopper for an intradermal delivery system |
WO2010019630A1 (en) * | 2008-08-13 | 2010-02-18 | Orizon Llc | Suture passer |
MX2011002655A (en) * | 2008-09-09 | 2011-06-16 | Baxter Int | Device to indicate priming of an infusion line. |
US8162875B2 (en) * | 2008-09-30 | 2012-04-24 | Tyco Healthcare Group Ip | Diluent/medication mixing syringe assembly |
US8454907B2 (en) | 2009-08-12 | 2013-06-04 | Orogen Holdings, Llc | Growth factor extractor |
US8641661B2 (en) * | 2010-01-05 | 2014-02-04 | Baxter International Inc. | Mixing system, kit and mixer adapter |
NZ735577A (en) | 2010-05-27 | 2019-05-31 | J&J Solutions Inc | Closed fluid transfer system |
US8973749B2 (en) | 2010-06-29 | 2015-03-10 | Biolyph, L.L.C. | Reagent preparation assembly |
AU2010363976B2 (en) | 2010-11-18 | 2015-05-21 | Biolyph, Llc | Reagent preparation and dispensing device |
ES2626275T3 (en) | 2011-01-10 | 2017-07-24 | Byeong Seon Chang | Compact medication reconstitution device and method |
CA2773271C (en) * | 2011-04-05 | 2016-10-11 | Tyco Healthcare Group Lp | Anesthetic syringe |
US8992505B2 (en) * | 2011-04-18 | 2015-03-31 | Thorne Consulting & Intellectual Property, LLC | Medical syringe filling and valving |
US9289562B2 (en) * | 2011-04-18 | 2016-03-22 | THORNE CONSULTING and INTELETUAL PROPERTY, LLC | Pressure actuated valve for multi-chamber syringe applications |
JP2014514109A (en) * | 2011-04-20 | 2014-06-19 | ノボ ノルディスク ヘルス ケア アーゲー | Fixing the piston rod |
EP2709698B1 (en) * | 2011-05-19 | 2018-01-24 | SHL Group AB | Device for medicament delivery with syringe-like usability having a restraining mechanism |
US8672883B2 (en) | 2011-07-11 | 2014-03-18 | C. Garyen Denning | Fluid delivery device and methods |
US9751056B2 (en) | 2012-01-23 | 2017-09-05 | Merit Medical Systems, Inc. | Mixing syringe |
US8834449B2 (en) | 2012-01-23 | 2014-09-16 | Ikomed Technologies, Inc. | Mixing syringe |
US9060724B2 (en) | 2012-05-30 | 2015-06-23 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
US9022951B2 (en) | 2012-05-30 | 2015-05-05 | Magnolia Medical Technologies, Inc. | Fluid diversion mechanism for bodily-fluid sampling |
US9174003B2 (en) | 2012-09-28 | 2015-11-03 | Bayer Medical Care Inc. | Quick release plunger |
EP3318295B1 (en) | 2012-10-11 | 2021-04-14 | Magnolia Medical Technologies, Inc. | System for delivering a fluid to a patient with reduced contamination |
EP4353151A2 (en) * | 2012-11-30 | 2024-04-17 | Magnolia Medical Technologies, Inc. | Syringe based fluid diversion mechanism for bodily-fluid sampling |
WO2014085118A1 (en) | 2012-11-30 | 2014-06-05 | Unitract Syringe Pty Ltd | Combination plunger device for a dual chamber mixing syringe |
US10772548B2 (en) | 2012-12-04 | 2020-09-15 | Magnolia Medical Technologies, Inc. | Sterile bodily-fluid collection device and methods |
US20150374925A1 (en) * | 2013-03-15 | 2015-12-31 | Windgap Medical, Llc | Portable Drug Mixing and Delivery Device and Associated Methods |
US20140296786A1 (en) * | 2013-03-29 | 2014-10-02 | Animas Corporation | Fluid cartridge for medical infusion device |
AU2014295975B2 (en) | 2013-08-02 | 2018-08-02 | J&J SOLUTIONS, INC. d.b.a CORVIDA MEDICAL | Compounding systems and methods for safe medicament transport |
US20160296703A1 (en) * | 2013-11-05 | 2016-10-13 | 3P Innovation Limited | A Pharmaceutical Component-Mixing Delivery Assembly |
EP3889172A1 (en) | 2014-02-10 | 2021-10-06 | Merck Patent GmbH | Targeted tgf beta inhibition |
PL3119453T3 (en) | 2014-03-19 | 2019-07-31 | Bayer Healthcare Llc | System for syringe engagement to an injector |
CN106102601B (en) * | 2014-04-18 | 2019-01-29 | 柯惠有限合伙公司 | Mixing syringe |
WO2016040360A1 (en) | 2014-09-09 | 2016-03-17 | Byeong Seon Chang | Solution delivery device and method |
USD807502S1 (en) | 2015-03-02 | 2018-01-09 | Neomed, Inc. | Enteral syringe |
USD831203S1 (en) | 2015-03-02 | 2018-10-16 | Neomed, Inc. | Enteral syringe |
USD831204S1 (en) | 2015-03-02 | 2018-10-16 | Neomed, Inc. | Enteral syringe |
US10624817B2 (en) | 2015-03-24 | 2020-04-21 | Neomed, Inc. | Oral administration coupler for back-of-mouth delivery |
JOP20200116A1 (en) | 2015-04-24 | 2017-06-16 | Amgen Inc | Methods for treating or preventing migraine headache |
EP3769681B1 (en) | 2015-06-12 | 2022-03-02 | Magnolia Medical Technologies, Inc. | Bodily-fluid sampling and transfer device |
JP6694501B2 (en) | 2015-07-14 | 2020-05-13 | ネオメッド,インクNeomed,Inc. | Dosage control joint for enteral fluid flow |
US10682287B2 (en) | 2015-07-14 | 2020-06-16 | Neomed, Inc. | Dosing control coupling for enteral fluid transfer and enteral couplings and syringes |
US10800597B2 (en) * | 2015-09-11 | 2020-10-13 | New Product Development Concepts Llc | Telescoping syringe with one-way valve |
US9850058B2 (en) | 2015-09-11 | 2017-12-26 | New Product Development Concepts Llc | Telescoping syringe with one-way valve |
AU2016323793B2 (en) | 2015-09-17 | 2021-03-11 | J&J SOLUTIONS, INC. d/b/a Corvida Medical | Medicament vial assembly |
MX2018004626A (en) | 2015-10-13 | 2018-08-01 | J&J Solutions Inc D/B/A Corvida Medical | Automated compounding equipment for closed fluid transfer system. |
US9480797B1 (en) | 2015-10-28 | 2016-11-01 | Bayer Healthcare Llc | System and method for syringe plunger engagement with an injector |
US10369292B2 (en) * | 2016-01-15 | 2019-08-06 | W. L. Gore & Associates, Inc. | Syringe plunger assemblies |
JP6914913B2 (en) * | 2016-03-29 | 2021-08-04 | テルモ株式会社 | How to use the drug solution administration device, how to use the drug solution administration device, and how to manufacture the drug solution administration device |
JPWO2017170634A1 (en) * | 2016-03-30 | 2019-02-07 | テルモ株式会社 | Seal member, syringe assembly, and prefilled syringe |
US9956143B2 (en) * | 2016-06-14 | 2018-05-01 | Pharmac, Llc | Syringe apparatus for transferring liquids into and out of a vial having a septum |
GB2556088A (en) * | 2016-11-18 | 2018-05-23 | Owen Mumford Ltd | Packaging and devices for mixing medicament substances |
AU2018205233A1 (en) * | 2017-01-07 | 2019-07-11 | Merck Patent Gmbh | Dosing regimens and dosage forms for targeted TGFβ inhibition |
KR20190102259A (en) * | 2017-01-10 | 2019-09-03 | 인트렉손 코포레이션 | Regulation of Polypeptide Expression Through a Novel Gene Switch Expression System |
CN111212597B (en) | 2017-09-12 | 2023-04-11 | 木兰医药技术股份有限公司 | Fluid control device and method of use |
EP3706828A4 (en) | 2017-11-09 | 2021-08-11 | Medeviceng | Syringe with dual nested chambers and method of use |
CA3087992A1 (en) | 2017-12-07 | 2019-06-13 | Magnolia Medical Technologies, Inc. | Fluid control devices and methods of using the same |
CA3092063A1 (en) | 2018-02-27 | 2019-09-06 | Bayer Healthcare Llc | Syringe plunger engagement mechanism |
WO2019189457A1 (en) * | 2018-03-28 | 2019-10-03 | 株式会社Cmc医薬 | Prefilled two-component-mixing syringe kit |
EP3774881A1 (en) | 2018-04-02 | 2021-02-17 | Amgen Inc. | Erenumab compositions and uses thereof |
US10959714B2 (en) * | 2018-04-19 | 2021-03-30 | Ethicon, Inc. | Dual syringe cartridge and housing |
WO2020036858A1 (en) | 2018-08-13 | 2020-02-20 | Monumedical, Llc | Syringe with multi-stage filling and dispensing |
WO2020163744A1 (en) | 2019-02-08 | 2020-08-13 | Magnolia Medical Technologies, Inc. | Devices and methods for bodily fluid collection and distribution |
KR102157612B1 (en) * | 2019-03-05 | 2020-09-18 | 김용현 | Syringe, drug mixing device, drug mixing kit comprising the same and method for manufacturing the same |
CN117100323A (en) | 2019-03-11 | 2023-11-24 | 木兰医药技术股份有限公司 | Fluid control device and method of using the same |
JP7423089B2 (en) | 2019-06-21 | 2024-01-29 | クリーデンス メドシステムズ,インコーポレイテッド | injection system |
WO2023095094A1 (en) * | 2021-11-29 | 2023-06-01 | University Of Miami | Ocular drug transfer and dispensing device |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2475939A (en) * | 1946-07-12 | 1949-07-12 | Applezweig Norman | Cartridge syringe |
US3489147A (en) * | 1964-07-21 | 1970-01-13 | Joseph Denman Shaw | Combination mixing and injecting medical syringe |
US3477432A (en) * | 1964-07-21 | 1969-11-11 | Joseph Denman Shaw | Combination mixing and injecting medical syringe |
US3255752A (en) * | 1965-01-28 | 1966-06-14 | Dick Peter | Hypodermic syringe |
US3838689A (en) * | 1970-11-04 | 1974-10-01 | M Cohen | Disposable syringe with slit valve |
US3757779A (en) * | 1971-05-24 | 1973-09-11 | Century Labor Inc | Filter syringe |
DE7128705U (en) * | 1971-07-26 | 1971-10-28 | Hampel H | STERILE PACKAGED SYRINGE CYLINDER OF A DISPOSABLE INJECTION SYRINGE WITH PISTON ROD RELEASABLE FROM THE PISTON |
US4153057A (en) * | 1975-07-24 | 1979-05-08 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Stopper for two-chamber mixing syringe |
US4172457A (en) * | 1977-10-06 | 1979-10-30 | American Hospital Supply Corporation | Plural component mixing system and method |
US4185628A (en) * | 1978-05-31 | 1980-01-29 | Kopfer Rudolph J | Compartmental syringe |
US4581016A (en) * | 1984-02-29 | 1986-04-08 | Gettig Pharmaceutical Instrument Co. | Dual cartridge wet/dry syringe |
US5088996A (en) * | 1984-04-16 | 1992-02-18 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
US4886495A (en) * | 1987-07-08 | 1989-12-12 | Duoject Medical Systems Inc. | Vial-based prefilled syringe system for one or two component medicaments |
GB2203047B (en) * | 1987-02-27 | 1991-01-30 | Gilbert Henry Banks | Single-use syringe |
DE3816961A1 (en) * | 1987-07-21 | 1989-02-02 | Wasserburger Arzneimittelwerk | INJECTION SYRINGE FOR MEDICAL PURPOSES |
US5067998A (en) * | 1987-12-21 | 1991-11-26 | General Electric Company | Fibrous material-containing composite |
US4957637A (en) * | 1988-05-23 | 1990-09-18 | Sherwood Medical Company | Serum separator system for centrifuge with piercable membrane |
FR2641191B2 (en) * | 1988-06-03 | 1991-03-15 | Clotteau Jean | SINGLE INJECTION SYRINGE |
US5407431A (en) * | 1989-07-11 | 1995-04-18 | Med-Design Inc. | Intravenous catheter insertion device with retractable needle |
US5135507A (en) * | 1990-05-10 | 1992-08-04 | Habley Medical Technology Corporation | One-piece syringe |
CA2016870C (en) * | 1990-05-15 | 1994-03-29 | Arnie Drudik | Dispenser for storing and mixing several components |
DK174390D0 (en) * | 1990-07-20 | 1990-07-20 | Novo Nordisk As | two-chamber injector |
DK288590D0 (en) * | 1990-12-04 | 1990-12-04 | Michael Morris | MIXTURE / SOLUTION SPRAY FOR CYTOSTATICS FOR MEDICAL TREATMENT OF CANCER PATIENTS |
US5181909A (en) * | 1991-05-15 | 1993-01-26 | Mcfarlane Richard H | Ampule-container medical syringe and methods |
US5158546A (en) * | 1991-08-07 | 1992-10-27 | Habley Medical Technology Corp. | Controlled action self-mixing vial |
US5289858A (en) * | 1991-12-18 | 1994-03-01 | Abbott Laboratories | System for accommodating withdrawal of liquid from a bulk supply |
US5496288A (en) * | 1992-09-23 | 1996-03-05 | Becton, Dickinson And Company | Protective cap for hypodermic syringe |
JP3172005B2 (en) * | 1992-11-27 | 2001-06-04 | 株式会社大協精工 | Syringe and container |
NZ258210A (en) * | 1992-12-01 | 1997-06-24 | Tetsuro Higashikawa | Syringe with a plurality of chambers |
US5370621A (en) * | 1992-12-14 | 1994-12-06 | Mallinckrodt Medical, Inc. | Insert device for facilitating limited aspiration of a delivery apparatus |
US5298024A (en) * | 1992-12-28 | 1994-03-29 | Frank Richmond | Multi-liquid medicament delivery system with reflex valves |
US5520657A (en) * | 1993-08-09 | 1996-05-28 | Sellers; Jackie | Method and device for vessel location cannulation utilizing a unique needle and syringe device |
US5372586A (en) * | 1993-10-20 | 1994-12-13 | Habley Medical Technology Corp. | Telescoping pharmaceutical storage and mixing syringe |
US5569193A (en) * | 1995-03-22 | 1996-10-29 | Abbott Laboratories | Syringe system accommodating separately storable prefilled containers for two constituents |
-
1996
- 1996-03-15 US US08/616,798 patent/US5785682A/en not_active Expired - Fee Related
- 1996-03-21 DK DK96908888T patent/DK0817654T3/en active
- 1996-03-21 PT PT96908888T patent/PT817654E/en unknown
- 1996-03-21 WO PCT/US1996/003913 patent/WO1996029106A2/en active IP Right Grant
- 1996-03-21 JP JP52862996A patent/JP3803933B2/en not_active Expired - Fee Related
- 1996-03-21 ES ES96908888T patent/ES2184856T3/en not_active Expired - Lifetime
- 1996-03-21 DE DE69623268T patent/DE69623268T2/en not_active Expired - Fee Related
- 1996-03-21 EP EP96908888A patent/EP0817654B1/en not_active Expired - Lifetime
- 1996-03-21 AT AT96908888T patent/ATE222784T1/en not_active IP Right Cessation
- 1996-03-21 CA CA002215912A patent/CA2215912C/en not_active Expired - Fee Related
- 1996-03-21 AU AU52582/96A patent/AU696759B2/en not_active Ceased
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109890436A (en) * | 2016-11-01 | 2019-06-14 | 赛诺菲-安万特德国有限公司 | Feedback mechanism for injection device |
CN109890436B (en) * | 2016-11-01 | 2022-12-02 | 赛诺菲-安万特德国有限公司 | Feedback mechanism for an injection device |
Also Published As
Publication number | Publication date |
---|---|
JP3803933B2 (en) | 2006-08-02 |
ATE222784T1 (en) | 2002-09-15 |
DE69623268D1 (en) | 2002-10-02 |
CA2215912A1 (en) | 1996-09-26 |
AU696759B2 (en) | 1998-09-17 |
JPH11502731A (en) | 1999-03-09 |
PT817654E (en) | 2003-01-31 |
EP0817654B1 (en) | 2002-08-28 |
WO1996029106A2 (en) | 1996-09-26 |
EP0817654A2 (en) | 1998-01-14 |
US5785682A (en) | 1998-07-28 |
DK0817654T3 (en) | 2003-01-06 |
ES2184856T3 (en) | 2003-04-16 |
AU5258296A (en) | 1996-10-08 |
WO1996029106A3 (en) | 1996-10-24 |
DE69623268T2 (en) | 2003-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2215912C (en) | Pre-filled syringe drug delivery system | |
CA2216926C (en) | Syringe barrel for lyophilization, reconstitution and administration | |
US6558365B2 (en) | Fluid transfer device | |
US7678333B2 (en) | Fluid transfer assembly for pharmaceutical delivery system and method for using same | |
US5566729A (en) | Drug reconstitution and administration system | |
US5876372A (en) | Syringe system accomodating seperate prefilled barrels for two constituents | |
US5766147A (en) | Vial adaptor for a liquid delivery device | |
EP1592381B1 (en) | Pharmaceutical delivery systems | |
US20240108548A1 (en) | Pre-filled diluent syringe vial adapter | |
KR0160306B1 (en) | Suction transfer assembly | |
EP0692235A1 (en) | Mixing & dispensing apparatus | |
US6245041B1 (en) | Fluid dispenser with fill adapter | |
JPH01131671A (en) | Injector | |
US8915902B2 (en) | Inter vial transfer system | |
JPH01500969A (en) | Connector for pharmaceutical containers and disposable assembly using the same | |
MXPA06001403A (en) | Coupling syringe system and methods for obtaining a mixed composition. | |
KR20220002472A (en) | Liquid Delivery Device With Dual Lumen IV Spike | |
JPH03149061A (en) | Double injecting device | |
JP2001502938A (en) | Syringe system containing two separate prefilled barrels | |
JP3759244B2 (en) | Syringe | |
WO2023126699A1 (en) | Pressure compensation device for reconstitution, withdrawal and transfer of a drug from a vial or other vacuum container, and apparatus comprising the above said device | |
JPH03133456A (en) | Device for storing, preparing and using drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |